WO2005105175A1 - Appareil de nettoyage de blessures a ultrasons - Google Patents

Appareil de nettoyage de blessures a ultrasons Download PDF

Info

Publication number
WO2005105175A1
WO2005105175A1 PCT/GB2005/001584 GB2005001584W WO2005105175A1 WO 2005105175 A1 WO2005105175 A1 WO 2005105175A1 GB 2005001584 W GB2005001584 W GB 2005001584W WO 2005105175 A1 WO2005105175 A1 WO 2005105175A1
Authority
WO
WIPO (PCT)
Prior art keywords
wound
fluid
cleansing
dressing
recirculation
Prior art date
Application number
PCT/GB2005/001584
Other languages
English (en)
Inventor
Patrick Lewis Blott
Clare Green
Robin Martin
Bryan Greener
Edward Yerbury Hartwell
Julian Lee-Webb
Derek Nicolini
Original Assignee
Smith & Nephew, Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew, Plc filed Critical Smith & Nephew, Plc
Publication of WO2005105175A1 publication Critical patent/WO2005105175A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0229—Devices operating in a closed circuit, i.e. recycling the irrigating fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71—Suction drainage systems
    • A61M1/77—Suction-irrigation systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84—Drainage tubes; Aspiration tips
    • A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91—Suction aspects of the dressing
    • A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0204—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity
    • A61M3/0208—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity before use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0204—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity
    • A61M3/0212—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity after use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0204—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity
    • A61M3/0216—Pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0204—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity
    • A61M3/022—Volume; Flow rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/94—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with gas supply means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/96—Suction control thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/058—General characteristics of the apparatus combined with other kinds of therapy with ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy

Definitions

  • the present invention relates to apparatus and a medical wound dressing for irrigating, supplying high frequency vibrational, in particular ultrasonic, energy to and/or cleansing wounds, and a method of treating wounds using such apparatus for irrigating, supplying high frequency vibrational, in particular ultrasonic, energy to and/or cleansing wounds.
  • aspirating and/or irrigating wounds and apparatus therefor were known, and tended to be used to remove wound exudate during wound therapy.
  • the offtake from the wound especially when in a highly exuding state, is voided to waste, e.g. to a collection bag.
  • Dialysis is a known method of treating bodily fluids such as blood ex vivo, to cleanse them of materials that are deleterious to the body systemically. Retaining materials that are beneficial in some therapeutic aspect in the treated fluid is not an object of dialysis.
  • This method of treating bodily fluids is also a systemic therapy, since the treated fluid is returned to within the body. This is in contrast to a topical therapy in which the treated fluid is recycled outside the body, e.g. to a wound.
  • Dialysis also requires large amounts either of bodily fluids, such as blood, or of dialysate, and consequently the relevant devices tend not to be portable. Even when in a highly exuding state, chronic wounds produce relatively little fluid to be treated and relatively little materials that are beneficial in some therapeutic aspect to be retained in the wound and/or its environment.
  • wound dressing and aspiration and/or irrigation therapy systems often create a wound environment under the backing layer that may result in the loss of optimum performance of the body's own tissue healing processes, and slow healing and/or in weak new tissue growth that does not have a strong three-dimensional structure adhering well to and growing from the wound bed. This is a significant disadvantage, in particular in chronic wounds.
  • High frequency vibrational, in particular ultrasonic, energy on and/or in a wound bed surface has been found to result in an improved breaking strength of tissue growth that has a strong three-dimensional structure adhering well to and growing from the wound bed, and reduction of wound recurrence.
  • High frequency vibrational, in particular ultrasonic, energy across the wound bed may also advantageously act against wound bacteria, by a) breaking up biofilm growth before it develops a strong three-dimensional structure adhering well to and growing from the wound bed, b) releasing them to be attacked by the body in the wound, and/or c) breaking up the bacterial cell wall at higher intensities.
  • an apparatus for aspirating, irrigating and/or cleansing wounds characterised in that it comprises a) a fluid flow path, comprising i) a conformable wound dressing, having a backing layer which is capable of forming a relatively fluid-tight seal or closure over a wound and at least one inlet pipe for connection to a fluid supply tube, which passes through and/or under the wound-facing face, and and at least one outlet pipe for connection to a fluid offtake tube, which passes through and/or under the wound-facing face, the point at which the or each inlet pipe and the or each outlet pipe passes through and/or under the wound-facing face forming a relatively fluid-tight seal or closure over the wound, at least one inlet pipe being connected to a fluid recirculation tube, and at least one outlet pipe being connected to a fluid offtake tube: and ii) a means for fluid cleansing having at least one inlet port connected to a fluid offtake tube and at least one outlet port connected to
  • any pipe in connection with the apparatus as being connected or for connection to a (mating end of a) tube, e.g. a fluid supply tube, fluid recirculation tube or fluid offtake tube
  • the pipe and the tube may form a single integer in the flow path through which the circulating fluid from the wound passes.
  • the means for applying high frequency vibrational, in particular ultrasonic, energy to the wound bed via the irrigant fluid and/or wound exudate may be an high frequency vibrational, in particular ultrasonic, sonode and/or a component of the apparatus flow path connected to a sonode, the sonic conductivity of which is sufficient for it to function as an high frequency vibrational, in particular ultrasonic, conductor.
  • the source of the ultrasound field may be integral with the sonode, or it may be connected to it by means for an high frequency vibrational, in particular ultrasonic, connection, typically a sonically insulated but conductive waveguide.
  • the desired or optimum intensities and frequencies of such ultrasound across the wound bed for the stimulation of the healing of wounds will substantially determine a) the position along the apparatus flow path or the component of the apparatus flow path where the means for applying high frequency vibrational, in particular ultrasonic, energy to the wound bed and/or conductively heated component of the apparatus flow path is mounted relative to the dressing; b) the flow rate of irrigant fluid and/or wound exudate; c) the intensity of ultrasound at the point of supply of energy to apparatus that is necessary given the level of energy loss in the system in which the fluid recirculates and energy is conducted to the wound; and/or d) the nature of the ultrasound source.
  • the means may be at any convenient or appropriate position or component of the apparatus flow path.
  • Examples include a means for applying high frequency vibrational, in particular ultrasonic, energy to the wound bed and/or conductively connected component of the apparatus flow path a) mounted distally of the body on, in or inside of the dressing; b) mounted in, on, at or near one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer; c) mounted in, on, at or near one or more of the connectors in the tubes that form the flow path of the apparatus; d) mounted in, on, at or near the reservoir ; and/or e) mounted in, on, at or near the means for fluid cleansing.
  • the level of energy loss in the system in which the fluid recirculates and energy is conducted to the wound; and/or the nature of the ultrasound source means that a convenient or appropriate position or component of the apparatus flow path for applying high frequency vibrational, in particular ultrasonic, energy to the wound bed and/or conductively connected component of the apparatus flow path is on, in or inside of the dressing and/or in, on, at or near one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of its backing layer.
  • Both longitudinal and shear waves generated by a transducer mechanism and/or shear waves generated by such longitudinally propagating waves provide effective healing of wounds. All these types of waves may propagate directly to the wound. Topically applied longitudinal waves may also be reflected by underlying bone tissue and skin layers and these and shear waves generated by them propagate towards the wound for the healing thereof
  • the transducer should be arranged having an operating surface, with the transducer, disposed substantially adjacent to the wound to emit ultra sound to propagate in the direction of the wound for healing thereof.
  • the transducer may include an axis and a focusing element for focusing the propagation of the ultrasound at a predetermined angle with respect to the axis
  • High frequency vibrational, in particular ultrasonic, energy, as is applied in the invention as an ultrasound field to the wound bed and/or the fluid thereover is characterised by parameters such as intensity, frequency, wave form and whether it is slow-pulsed either regularly or randomly on the overall ultrasound waveform.
  • suitable intensities of ultrasound applied include a spatial peak temporal average acoustic intensity between 5 - 100 mW/cm 2 , e.g. 10 to 75 mW/cm 2 , such as 30 to 50 mW/cm 2 . When the ultrasound is slow-pulsed, this allows higher peak intensities.
  • suitable frequencies of ultrasound across the wound bed for the stimulation of the healing of wounds include in general an ultrasound carrier frequency between 20 kHz and 10 MHz, such as 60 kHz to 5 MHz, such as 200 kHz to 3 MHz.
  • suitable waveforms of ultrasound across the wound bed for the stimulation of the healing of such wounds include those described in detail in WO 99/56829, WO 99/48621 and US 5,904,659, all of which are incorporated herein by way of reference optionally slow-pulsed either regularly or randomly on the overall ultrasound waveform.
  • These may be optionally slow-pulsed either regularly or randomly on the overall vibrational waveform with a relatively low-frequency modulating signal.
  • Examples of suitable pulsing of ultrasound on/across the wound bed for the stimulation of the healing of wounds include pulsing at low frequencies such as 5 Hz to 10kHz.
  • Application may be made continuously or intermittently, for example 1-4 times daily for a period of 20 minutes per application.
  • the apparatus for irrigating, supplying high frequency vibrational, in particular ultrasonic, energy to and/or cleansing wounds of the present invention is characterised in that it comprises at least one sonode for applying a vibrational field to the wound bed and/or the fluid thereover.
  • the source of the sound field may be connected to the sonode by means for an high frequency vibrational, in particular ultrasonic, connection, typically a sonically insulated but conductive waveguide, or it may be integral with or comprise it
  • the source may be of any conventional type, e.g., in the case of ultrasound, a piezoelectric transducer; or others described in detail in WO 99/56829, WO 99/48621 and US 5,904,659, all of which are incorporated herein by way of reference.
  • Suitable materials for the sonode include materials that do not absorb high- frequency vibrational or ultrasonic energy, such as an Exogen TM device.
  • Suitable materials for the waveguides include ultrasound-conductive materials such as those described in detail in WO 99/56829, WO 99/48621 and US 5,904,659, all of which are incorporated herein by way of reference.
  • Examples of instances where the sonode effectively is or is integral with the ultrasonic source, include a piezoelectric transducer directly attached to or integral with a component of the apparatus flow path.
  • Suitable materials for such a piezoelectric transducing sonode include those described in detail in WO 99/56829, WO 99/48621 and US 5,904,659, all of which are incorporated herein by way of reference.
  • polymeric materials such as certain halogenated polyolefins, such as fluorinated olefin polymers and copolymers, such as polyvinylidene fluoride and copolymers thereof.
  • suitable materials also include thermoplastics, and elastomers and elastomer blends, having for example particulate piezoelectric dispersed through it, such as the certain halogenated polyolefins, such as fluorinated olefin polymers and copolymers, such as polyvinylidene fluoride and copolymers thereof mentioned above; and certain minerals, such as quartz.
  • thermoplastics, and elastomers and elastomer blends having for example particulate piezoelectric dispersed through it, such as the certain halogenated polyolefins, such as fluorinated olefin polymers and copolymers, such as polyvinylidene fluoride and copolymers thereof mentioned above; and certain minerals, such as quartz.
  • thermoplastics materials and elastomers and elastomer blends include synthetic polymeric materials that do not absorb aqueous fluids, such as polyolefins, such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof; polysiloxanes; polyesters, such as polycarbonates; polyamides, e.g. nylon 6 - 6 and 6 - 10, and hydrophobic polyurethanes.
  • polyolefins such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof
  • polysiloxanes such as polycarbonates
  • polyamides e.g. nylon 6 - 6 and 6 - 10
  • hydrophobic polyurethanes such as polyurethanes.
  • They may be hydrophilic, and thus also include hydrophilic polyurethanes. They also include thermoplastic elastomers and elastomer blends, for example copolymers, such as ethyl vinyl acetate, optionally or as necessary blended with high-impact polystyrene.
  • elastomeric polyurethane particularly polyurethane formed by solution casting.
  • the source is or includes a piezoelectric transducer, it will be electrically stimulated to change shape repeatedly as appropriate or desired at ultrasonic frequencies by an ultrasonic frequency electrical signal generator run at the appropriate frequencies.
  • the sonode or sonode-transducer may be mounted at any convenient or appropriate position or component of the apparatus flow path. Typically, however, as noted above, it is a) mounted distally of the body on, in or inside of the dressing; and/or b) mounted in, on, at or near one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer.
  • the sonode or sonode-transducer is outside the dressing, since otherwise it requires that a waveguide or electric leads will pass through and/or under the wound- facing face of the backing layer, and the point at which it passes or they through and/or under the wound-facing face must form a relatively fluid-tight seal or closure over the wound.
  • the wound dressing may then effectively be capable of being electrically stimulated to change shape repeatedly as appropriate or desired at high frequency vibrational, in particular ultrasonic, frequencies.
  • the sonode or sonode-transducer is mounted distally of the body on, in or inside of the dressing, it will often be at or near the centre of the dressing backing layer.
  • the sonode/transducer may be in the form of a relatively laminar integer, for example a discoidal pellet, foil, film, sheet or membrane. It may be mounted to be clear of or surround one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer.
  • the sonode or sonode-transducer may be attached, as appropriate by heat- sealing or by adhesive, or it may be a push, slide, snap or twist-lock fit.
  • a sonode-transducer such as a film, sheet or membrane of or comprising a piezoelectric transducing polyolefin, such as polyvinylidene fluoride and copolymers thereof, may be attached, e.g. by an adhesive, in particular a curable adhesive, coextrusion or heat lamination to the dressing.
  • the backing layer may be mounted proximally on the backing layer to be clear of, surround or pass across one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer.
  • the sonode or sonode-transducer is attached as a push, slide, snap or twist-lock fit, it may for example be mounted distally or proximally on the backing layer clear of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer, as a push fit in a (respectively) distally or proximally projecting recessed boss.
  • a sonode such as an Exogen TM device may be a push fit in a distally projecting recessed boss on the distal backing layer surface.
  • a layer of ultrasound coupling material e.g. a coupling gel
  • a sonode-transducer for example a disc, film, sheet or membrane, of or comprising a piezoelectric, such as polyvinylidene fluoride and copolymers thereof mentioned above, may be mounted at any convenient or appropriate position, in or inside of the dressing, as a push fit in a proximally projecting recessed boss.
  • a piezoelectric such as polyvinylidene fluoride and copolymers thereof mentioned above
  • Such a sonode/transducer does not need to be connected ultrasonically to the dressing backing sheet by a layer of ultrasound coupling material, e.g. the adhesive or by a coupling gel, which is needed to transmit the energy to the irrigant and/or exudate under the wound-facing face of the wound dressing.
  • a layer of ultrasound coupling material e.g. the adhesive or by a coupling gel
  • the sonode or sonode-transducer may be mounted in, on, at or near one or more of the fluid inlet pipe(s) and outlet pipe(s) that pass through and/or under the wound-facing face of the backing layer,
  • the nature of the sonode or sonode-transducer, and the manner and position in which it may be mounted are similar to the those in the case of mounting in or on the dressing mutatis mutandis.
  • Mounting in, on, at or near one or more of the fluid inlet pipe(s) and outlet pipe(s) may however be less preferred than mounting on the backing layer at any convenient or appropriate position, since, because of the orientation of the pipes, it may be less easy to direct the high-frequency vibrational or ultrasonic energy sufficiently to achieve adequate therapeutic intensities across the wound bed for the stimulation of the healing of wounds.
  • Suitable dressings are depicted and described in more detail hereinafter.
  • the means for flow switching between supply and recirculation may take any form that enables the wound simultaneously to be a) put into communication with the fluid reservoir but b) closed to the fluid recirculation tube, and c) vice versa.
  • the fluid reservoir is connected by the fluid supply tube to the flow path via means for flow switching as desired the into a fluid recirculation tube or a fluid offtake tube.
  • the means for flow switching between supply and recirculation may be a regulator, such as a T- valve. This is connected in turn to two parts of a fluid recirculation tube or a fluid offtake tube and the fluid supply tube, such that the desired flow switching between supply and recirculation is achieved.
  • inlet pipes may be connected respectively to a fluid supply tube or fluid recirculation tube, respectively having a first regulator and a second regulator, such as a valve or other control device for admitting fluids into the wound.
  • the desired flow switching between supply and recirculation is achieved by respectively having the first regulator open when the second regulator is shut, and vice versa.
  • the means for bleeding the flowpath may be situated in any appropriate part of the apparatus that is in contact with the irrigant and/or wound exudate, but is usually within the offtake and/or recirculation tubes. However, it is often as far downstream of and away from the reservoir and the fluid supply tube as possible, so that it may be used to prime the whole of the flowpath from the fluid reservoir via the fluid supply tube. It may be a regulator, such as a valve or other control device, e.g. a T-valve that is turned to switch between bleed and recirculation, for bleeding fluids from the apparatus, e.g. to a waste reservoir, such as a collection bag.
  • a regulator such as a valve or other control device, e.g. a T-valve that is turned to switch between bleed and recirculation, for bleeding fluids from the apparatus, e.g. to a waste reservoir, such as a collection bag.
  • flow switching between supply and recirculation may not be desired, but rather concomitant bleeding and/or recirculation is desired.
  • the latter may occur when the volume of irrigant and/or wound exudate in recirculation is increased by continuing addition to it of a) wound exudate, and/or b) fluid passing from a cleansing fluid through a selectively permeable integer, for example in a system such as a dialysis unit.
  • the means for bleeding the offtake and/or recirculation tubes may then be provided in the form of a regulator, such as a simple valve or other control device for admitting or blocking the passage of irrigant and/or exudate through a bleed line branching from the recirculation path.
  • a regulator such as a simple valve or other control device for admitting or blocking the passage of irrigant and/or exudate through a bleed line branching from the recirculation path.
  • the means for fluid cleansing may as desired be a 'single-phase system'.
  • the circulating fluid from the wound and the fluid reservoir passes through a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
  • a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
  • a two- phase system such as a dialysis unit, or a biphasic liquid extraction unit.
  • the circulating fluid from the wound and the fluid reservoir passes through a system in which the fluid recirculates in indirect or (less usually, direct) contact with a second fluid (dialysate) phase, more usually a liquid, in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
  • a second fluid dialysate phase
  • Such systems are described in further detail hereinafter in connection with the means for fluid cleansing.
  • the means for flow switching between supply and recirculation tubes is set to admit fluid into the wound from the fluid reservoir but to close the wound to the fluid recirculation tube.
  • any means for bleeding the offtake and/or recirculation tubes are is opened and the device for moving fluid through the wound and means for fluid cleansing is started.
  • the capacity of the apparatus flow path and the flow rate of irrigant and/or wound exudate from the wound will largely determine whether it is appropriate to run the device to prime the apparatus throughout the whole length of the apparatus flow path, i.e. to displace any existing fluid reservoir (often air) from the fluid recirculation path, and for how long it should be run.
  • the means for bleeding the offtake and/or recirculation tubes is closed, and the means for flow switching between supply and recirculation tubes is set to close the wound to the fluid reservoir but to admit fluid into the wound from the fluid recirculation tube.
  • the cleansing fluid is typically set in motion in contact with the surface of the selectively permeable integer, for example the polymer film, sheet or membrane.
  • the cleansing fluid may less usually be static, and then this step is omitted.
  • the volume of irrigant and/or wound exudate from the wound in recirculation may be increased by continuing addition to it of a) wound exudate, and/or b) fluid passing from a cleansing fluid through a selectively permeable integer, for example the polymer film, sheet or membrane of a two- phase system, such as an dialysis unit.
  • a selectively permeable integer for example the polymer film, sheet or membrane of a two- phase system, such as an dialysis unit.
  • a negative pressure to the wound by means of a device for moving fluid through the wound and means for fluid cleansing applied to the fluid in recirculation in the fluid recirculation tube downstream of and away from the wound dressing.
  • the volume of irrigant and/or wound exudate from the wound in recirculation may be decreased by continuing loss from it of fluid passing from a cleansing fluid through a selectively permeable integer, for example in a system such as a dialysis unit.
  • a positive pressure to the wound by means of a device for moving fluid through the wound and means for fluid cleansing applied to the fluid in recirculation in the fluid recirculation tube upstream of and towards the wound dressing.
  • the means for flow switching between supply and recirculation may be similarly provided in a form in which concomitant supply and/or recirculation is possible, and to make the necessary adjustments to maintain the desired balance of fluid in recirculation by means of the means for flow switching.
  • At least one hollow body in the recirculation flow path to and from the wound bed should have sufficient resilience against the pressure to allow any significant compression or decompression of the irrigant fluid to occur.
  • the type and material of such bodies (which are defined by a film, sheet or membrane) that are described by way of example herein to be suitable for use in the present invention will be largely capable of this function.
  • suitable materials for bodies defined by a film, sheet or membrane such as inlet or offtake and/or recirculation tubes and structures such as bags, chambers and pouches, filled with irrigant fluid, e.g. the backing layer of the wound dressing are suitably elastically resilient thermoplastic materials that are potentially capable of this function when pressure is applied in this way.
  • the present invention in this aspect provides several advantages.
  • This may be effected in therapeutically active amounts, to promote greater wound healing than by treatment with the fluid physiologically active component(s) alone.
  • physiologically active components of the exudate that are beneficial to wound healing may be e.g. be enzymes or other species and may be supplied from the dialysate of a dialytic means for fluid cleansing.
  • Circulating wound fluid aids in movement of biological signalling molecules involved in wound healing to locations in the wound bed that are favourable to the wound healing process and/or to cells that would otherwise not be exposed to them, e.g. in a highly exuding wound. This is especially the case in those embodiments of the apparatus of this first aspect of the present invention for aspirating, irrigating and/or cleansing wounds where there is an inlet or outlet manifold from which tubules radiate and run to the wound bed to end in openings that deliver and collect the fluid directly from the wound bed over an extended area.
  • Such materials include cytokines, enzymes, nutrients for wound cells to aid proliferation, oxygen, and other molecules that are beneficially involved in wound healing, such as growth factors, and others having beneficial effects (which may be further enhanced) in causing chemotaxis.
  • a particular advantage is the tendency of the wound dressing to conform to the shape of the bodily part to which it is applied.
  • the wound dressing comprises a backing layer with a wound-facing face which is capable of forming a relatively fluid-tight seal or closure over a wound and at least one inlet pipe for connection to a fluid supply tube or recirculation tube, which passes through and/or under the wound-facing face, and and at least one outlet pipe for connection to a fluid offtake tube, which passes through and/or under the wound-facing face, the point at which the or each inlet pipe and the or each outlet pipe passes through and/or under the wound-facing face forming a relatively fluid-tight seal or closure.
  • the term 'relatively fluid-tight seal or closure' is used herein to indicate one which is fluid- and microbe-impermeable and permits a positive or negative pressure of up to 50% atm., more usually up to 15% atm. to be applied to the wound.
  • the term 'fluid' is used herein to include gels, e.g. thick exudate, liquids, e.g. water, and gases, such as air, nitrogen, etc.
  • the shape of the backing layer that is applied may be any that is appropriate to aspirating, irrigating and/or cleansing the wound across the area of the wound.
  • examples of such include a substantially flat film, sheet or membrane, or a bag, chamber, pouch or other structure of the backing layer, e.g. of polymer film, which can contain the fluid.
  • the backing layer may be a film, sheet or membrane, often with a (generally uniform) thickness of up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness.
  • Its largest cross-dimension may be up to 500 mm (for example for large torso wounds), up to 100 mm (for example for axillary and inguinal wounds), and up to 200 mm for limb wounds (for example for chronic wounds, such as venous leg ulcers and diabetic foot ulcers.
  • the dressing is resiliently deformable, since this may result in increased patient comfort, and lessen the risk of inflammation of a wound.
  • Suitable materials for it include synthetic polymeric materials that do not absorb aqueous fluids, such as polyolefins, such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof; polysiloxanes; polyesters, such as polycarbonates; polyamides, e.g. nylon 6 - 6 and 6 - 10, and hydrophobic polyurethanes.
  • polyolefins such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof
  • polysiloxanes such as polycarbonates
  • polyamides e.g. nylon 6 - 6 and 6 - 10
  • hydrophobic polyurethanes such as polyurethanes.
  • They may be hydrophilic, and thus also include hydrophilic polyurethanes.
  • thermoplastic elastomers and elastomer blends for example copolymers, such as ethyl vinyl acetate, optionally or as necessary blended with high-impact polystyrene.
  • They further include elastomeric polyurethane, particularly polyurethane formed by solution casting.
  • Preferred materials for the present wound dressing include thermoplastic elastomers and curable systems.
  • the backing layer is capable of forming a relatively fluid-tight seal or closure over the wound and/or around the inlet and outlet pipe(s).
  • the wound dressing in particular around the periphery of the wound dressing, outside the relatively fluid-tight seal, it is preferably of a material that has a high moisture vapour permeability, to prevent maceration of the skin around the wound. It may also be a switchable material that has a higher moisture vapour permeability when in contact with liquids, e.g. water, blood or wound exudate. This may, e.g. be a material that is used in Smith & Nephew's AllevynTM, IV3000TM and OpSiteTM dressings.
  • the periphery of the wound-facing face of the backing layer may bear an adhesive film, for example, to attach it to the skin around the wound.
  • This may, e.g. be a pressure-sensitive adhesive, if that is sufficient to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound-facing face of the wound dressing.
  • a light switchable adhesive could be used to secure the dressing in place to prevent leakage.
  • a light switchable adhesive is one the adhesion of which is reduced by photocuring. Its use can be beneficial in reducing the trauma of removal of the dressing.
  • the backing layer may have a flange or lip extending around the proximal face of the backing layer, of a transparent or translucent material (for which it will be understood that materials that are listed above are amongst those that are suitable).
  • the layer of opaque material on the distal face of the flange or lip extending around the proximal wound is removed prior to application of radiation of an appropriate wavelength to the flange or lip.
  • the periphery of the wound dressing, outside the relatively fluid-tight seal, that bears an adhesive film to attach it to the skin around the wound is of a material that has a high moisture vapour permeability or is a switchable material
  • the adhesive film, if continuous, should also have a high or switchable moisture vapour permeability, e.g. be an adhesive such as used in Smith & Nephew's AllevynTM, IV3000TM and OpSiteTM dressings.
  • the wound dressing may be provided with a silicone flange or lip to seal the dressing around the wound. This removes the need for adhesives and associated trauma to the patient's skin.
  • the dressing is under any significant positive pressure, which will tend to act at peripheral points to lift and remove the dressing off the skin around the wound.
  • Examples of such means include light switchable adhesives, as above, to secure the dressing in place to prevent leakage.
  • a film of a more aggressive adhesive may be used, e.g. on a flange, as above.
  • suitable fluid adhesives for use in more extreme conditions where trauma to the patient's skin is tolerable include ones that consist essentially of cyanoacrylate and like tissue adhesives, applied around the edges of the wound and/or the proximal face of the backing layer of the wound dressing, e.g. on a flange or lip.
  • Such means include adhesive (e.g. with pressure-sensitive adhesive) and non-adhesive, and elastic and non-elastic straps, bands, loops, strips, ties, bandages, e.g. compression bandages, sheets, covers, sleeves, jackets, sheathes, wraps, stockings and hose, e.g. elastic tubular hose or elastic tubular stockings that are a compressive fit over a limb wound to apply suitable pressure to it when the therapy is applied in this way; and inflatable cuffs, sleeves, jackets, trousers, sheathes, wraps, stockings and hose that are a compressive fit over a limb wound to apply suitable pressure to it when the therapy is applied in this way.
  • adhesive e.g. with pressure-sensitive adhesive
  • non-adhesive e.g. with pressure-sensitive adhesive
  • elastic and non-elastic straps e.g. compression bandages, sheets, covers, sleeves, jackets, sheathes, wraps, stockings
  • Such means may each be laid out over the wound dressing to extend beyond the periphery of the backing layer of the wound dressing, and as appropriate will be adhered or otherwise secured to the skin around the wound and/or itself and as appropriate will apply compression (e.g. with elastic bandages, stockings) to a degree that is sufficient to hold the wound dressing in place in a fluid-tight seal around the periphery of the wound,
  • compression e.g. with elastic bandages, stockings
  • Such means may each be integral with the other components of the dressing, in particular the backing layer.
  • the dressing may be permanently attached or releasably attached to the dressing, in particular the backing layer, with an adhesive film, for example, or these components may be a Velcro TM, push snap or twist-lock fit with each other.
  • the means and the dressing may be separate structures, permanently unattached to each other.
  • a stiff flange or lip extends around the periphery of the proximal face of the backing layer of the wound dressing as hereinbefore defined.
  • the flange or lip is concave on its proximal face to define a peripheral channel or conduit.
  • the backing layer may be integral with or attached, for example by heat- sealing, to the flange or lip extending around its proximal face.
  • the dressing is set on the skin around the wound.
  • the device then applies a vacuum to the interior of the flange or lip, thus forming and maintaining a seal or closure acting at peripheral points around the wound against the positive pressure on the wound.
  • the wound dressing sealing periphery is preferably of a generally round shape, such as an ellipse, and in particular circular.
  • the backing layer may be integral with these other components.
  • the components may alternatively just be a push, snap or twist-lock fit with each other, or adhered or heat-sealed together.
  • each inlet pipe or outlet pipe may be in the form of an aperture, such as a funnel, hole, opening, orifice, luer, slot or port for connection as a female member respectively to a mating end of a fluid recirculation tube and/or fluid supply tube (optionally or as necessary via means for forming a tube, pipe or hose, or nozzle, hole, opening, orifice, luer, slot or port for connection as a male member respectively to a mating end of a fluid recirculation tube and/or fluid supply tube (optionally or as necessary via means for flow switching between supply and recirculation) or a fluid offtake tube.
  • an aperture such as a funnel, hole, opening, orifice, luer, slot or port for connection as a female member respectively to a mating end of a fluid recirculation tube and/or fluid supply tube (optionally or as necessary via means for forming a tube, pipe or hose, or nozzle, hole, opening, orifice, luer, slot or port
  • the backing layer may often have a rigid and/or resiliently inflexible or stiff area to resist any substantial play between the or each pipe and the or each mating tube, or deformation under pressure in any direction.
  • each relevant tube, pipe or hose, or nozzle, hole, opening, orifice, luer, slot or port for connection to a mating end of a fluid recirculation tube and/or fluid supply tube or fluid offtake tube.
  • the backing layer may have a stiff flange or lip extending around the proximal face of the backing layer to stiffen, reinforce or otherwise strengthen the backing layer.
  • the wound dressing may not comprise any integer under the backing layer in the wound in use.
  • one form of the dressing is provided with a 'tree' form of pipes, tubes or tubules that radiate from an inlet manifold to the wound bed to end in apertures and deliver the circulating fluid directly to the wound bed via the apertures.
  • an outlet manifold from which tubules radiate and run to the wound bed to end in openings and collect the fluid directly from the wound bed.
  • the pipes, etc. may radiate regularly or irregularly through the wound in use, respectively from the inlet or outlet manifold, although regularly may be preferred.
  • a more suitable layout for deeper wounds is one in which the pipes, etc. radiate hemispherically and concentrically, to the wound bed.
  • suitable forms of such layout of the pipes, etc. include ones in which the pipes, etc. radiate in a flattened hemiellipsoid and concentrically, to the wound bed.
  • suitable forms of layout of the pipes, etc. include one which have pipes, tubes or tubules extending from the inlet pipe(s) and/or outlet pipe(s) at the point at which they pass through and/or under the wound-facing face of the backing layer to run over the wound bed. These may have a blind bore with perforations, apertures, holes, openings, orifices, slits or slots along the pipes, etc.
  • tubes, pipes or tubules are resiliently flexible, e.g. elastomeric, and preferably soft, structures with good conformability in the wound and the interior of the wound dressing.
  • the layout of the tubes, pipes, tubules, etc. may depend on the depth and/or capacity of the wound.
  • suitable forms of such layout of the tubes, pipes, tubules, etc. include ones that consist essentially of one or more of the tubes, etc in a spiral.
  • a more suitable layout for deeper wounds when the therapy is applied in this way may be one which comprises one or more of the tubes, etc in a helix or spiral helix.
  • Other suitable layouts for shallower wounds include one which have blind- bore, perforated inlet pipe or outlet pipe manifolds that circulate fluid in the wound when the dressing is in use.
  • One or both of these may be such a form, the other may be, e.g. one or more straight blind-bore, perforated radial tubes, pipes or nozzles.
  • FIG. 10a there is shown an exploded isometric view of such a stack, which is non- limiting.
  • a manifold such as a) an open-celled or reticulated foam or b) a hollow body defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, containing a fluid
  • a film, sheet or membrane such as a bag, chamber, pouch or other structure, containing a fluid
  • aqueous fluid such as water, saline or other irrigant fluid and wound exudate.
  • multi-layer manifolds such as those described immediately above may absorb ultrasound energy to a significant extent, so that the position of the sonode may have to be adjusted to mitigate this effect.
  • the backing layer that is applied may be any that is appropriate to the present system of therapy and permits a positive or negative pressure of up to 50% atm., more usually up to 25% atm. to be applied to the wound.
  • microbe-impermeable film, sheet or membrane which is substantially flat, depending on any pressure differential on it, and often with a (generally uniform) thickness similar to such films or sheets used in conventional wound dressings. That is, up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness.
  • the backing layer may often have a rigid and/or resiliently inflexible or stiff area to resist any substantial play between other components that are not mutually integral, and may be stiffened, reinforced or otherwise strengthened, e.g. by a projecting boss.
  • Such a form of dressing would not be very conformable to the wound bed, and may effectively form a chamber, hollow or cavity defined by a backing layer and the wound bed under the backing layer.
  • one form of the dressing is provided with a wound filler under the backing layer.
  • This is favourably a resiliently flexible, e.g. elastomeric, and preferably soft, structure with good conformability to wound shape.
  • the wound filler may be integral with the other components of the dressing, in particular the backing layer. Alternatively, it may be permanently attached to them/it, with an adhesive film, for example, or by heat-sealing, e.g. to a flange or lip extending from the proximal face, so a not to disrupt the relatively fluid-tight seal or closure over the wound that is needed.
  • the wound filler is releasably attached to the backing layer, with an adhesive film, for example, or these components may be a push, snap or twist-lock fit with each other.
  • the wound filler and the backing layer may be separate structures, permanently unattached to each other.
  • the wound filler may be or comprise a solid integer, favourably a resiliently flexible, e.g. elastomeric, and preferably soft, structure with good conformability to wound shape.
  • suitable forms of such wound fillers are foams formed of a suitable material, e.g. a resilient thermoplastic.
  • Preferred materials for the present wound dressing include reticulated filtration polyurethane foams with small apertures or pores.
  • it may be in the form of, or comprise one or more conformable hollow bodies defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, filled with a fluid or solid that urges it to the wound shape.
  • a film, sheet or membrane such as a bag, chamber, pouch or other structure, filled with a fluid or solid that urges it to the wound shape.
  • the film, sheet or membrane often has a (generally uniform) thickness similar to that of films or sheets used in conventional wound dressing backing layers.
  • micron up to 100 micron, preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness, and is often resiliently flexible, e.g. elastomeric, and preferably soft.
  • Such a filler is often integral with the other components of the dressing, in particular the backing layer, or permanently attached to them/it, with an adhesive film, for example, or by heat-sealing, e.g. to a flange
  • suitable fluids contained in the hollow body or bodies defined by a film, sheet or membrane include gases, such as air, nitrogen and argon, more usually air, at a small positive pressure above atmospheric; and liquids, such as water, saline.
  • Examples also include gels, such as silicone gels, e.g. CaviCareTM gel, or preferably cellulosic gels, for example hydrophilic cross-linked cellulosic gels, such as Intrasite TM cross-linked materials.
  • gels such as silicone gels, e.g. CaviCareTM gel, or preferably cellulosic gels, for example hydrophilic cross-linked cellulosic gels, such as Intrasite TM cross-linked materials.
  • examples also include aerosol foams, where the gaseous phase of the aerosol system is air or an inert gas, such as nitrogen or argon, more usually air, at a small positive pressure above atmospheric; and solid particulates, such as plastics crumbs.
  • a wound filler such as a) an open-celled or reticulated foam or b) a hollow body defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, containing a fluid, should not substantially interfere with the transfer of ultrasound provided it respectively a) is saturated with an appropriate transfer medium (e.g. irrigant fluid and/or wound exudate), or b) the hollow body defined by a film, sheet, etc contains an aqueous fluid, such as water, saline or a cellulosic gel, for example hydrophilic cross-linked cellulosic gels, such as Intrasite TM cross-linked materials.
  • an aqueous fluid such as water, saline or a cellulosic gel, for example hydrophilic cross-linked cellulosic gels, such as Intrasite TM cross-linked materials.
  • a gas-containing filler between ultrasound sonode and wound bed e.g. an air bag
  • the ultrasound sonode will have to be located in order to establish ultrasonic contact with the wound bed via a suitable transfer medium (e.g. it will be located under the air bag).
  • the backing layer is a sufficiently conformable and/or e.g. an upwardly dished sheet, the backing layer may lie under the wound filler, rather than vice versa.
  • the wound filler in order for the wound filler to urge the wound dressing towards the wound bed, it will usually have to be firmly adhered or otherwise releasably attached to the skin around the wound. This is especially the case in those embodiments where the wound filler and the backing layer are separate structures, permanently unattached to each other.
  • the means for such attachment may also form and maintain a seal or closure over the wound.
  • the fluid inlet pipe(s) and outlet pipe(s) may run through or around the wound filler over the backing layer.
  • a wound filler under the backing layer that is or comprises a resiliently flexible, e.g. elastomeric, and preferably soft, hollow body defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, with apertures, holes, openings, orifices, slits or slots, or tubes, pipes, tubules or nozzles. It communicates with at least one inlet or outlet pipe through at least one aperture, hole, opening, orifice, slit or slot.
  • a resiliently flexible e.g. elastomeric, and preferably soft, hollow body defined by a film, sheet or membrane, such as a bag, chamber, pouch or other structure, with apertures, holes, openings, orifices, slits or slots, or tubes, pipes, tubules or nozzles.
  • the fluid contained in the hollow body may then be the circulating fluid in the apparatus.
  • the hollow body or each of the hollow bodies then effectively forms an inlet pipe or outlet pipe manifold that delivers the circulating fluid directly to the wound bed or collects the fluid directly from the wound respectively via the holes, openings, orifices, slits or slots, or the tubes, pipes or hoses, etc. in the film, sheet or membrane.
  • the type of the filler may also be largely determined by the depth and/or capacity of the wound.
  • a more suitable wound filler for deeper wounds when the therapy is applied in this way may be one which comprises one or more conformable hollow bodies defined by, for example a polymer film, sheet or membrane, that at least partly surround(s) a solid integer. This may provide a system with better rigidity for convenient handling.
  • the wound filler under the backing layer effectively forms an inlet pipe or outlet pipe manifold, in order for good aspiration and/or irrigation of the wound bed to occur, it is appropriate for one or more bores, channels, conduits, passages, pipes, tubes, tubules and/or spaces, etc. to run a) from the point at which the fluid inlet pipe(s) and outlet pipe(s) pass through and/or under the wound-facing face of the backing layer b) through or around the wound filler under the backing layer.
  • the wound filler is an open-cell foam with pores that may form such bores, channels, conduits, passages and/or spaces through the wound filler under the backing layer.
  • the filler is or comprises one or more conformable hollow bodies defined by, for example a polymer film, sheet or membrane, it may be provided with means for admitting fluids to the wound bed under the wound dressing.
  • These may be in the form of pipes, tubes, tubules or nozzles running from the point at which the fluid inlet pipe(s) and outlet pipe(s) pass through and/or under the wound-facing face of the backing layer through or around the wound filler under the backing layer.
  • suitable layouts include ones where one or both manifolds are annular or toroidal (regular, e.g. elliptical or circular, or irregular), optionally with blind-bore, perforated radial tubes, pipes or nozzles, branching from the annulus or torus; and/or in a meandering, tortuous, winding, zigzag, serpentine or boustrophedic (i.e. in the manner of a ploughed furrow) pattern, or defined by slots in and apertures through layers attached to each other in a stack.
  • annular or toroidal regular, e.g. elliptical or circular, or irregular
  • blind-bore perforated radial tubes, pipes or nozzles, branching from the annulus or torus
  • a meandering tortuous, winding, zigzag, serpentine or boustrophedic (i.e. in the manner of a ploughed furrow) pattern, or defined by slots in and apertures through layers attached
  • the inlet and/or outlet tubes, the fluid recirculation tube and the fluid supply tube, etc. may be of conventional type, e.g. of elliptical or circular cross- section, and may suitably have a uniform cylindrical bore, channel, conduit or passage throughout their length.
  • the largest cross-dimension of the bore may be up to 10 mm for large torso wounds, and up to 2 mm for limb wounds.
  • the tube walls should suitably thick enough to withstand any positive or negative pressure on them, in particular if the volume of irrigant and/or wound exudate from the wound in recirculation is increased by continuing addition to it of wound exudate, and/or fluid passing from a cleansing fluid through a selectively permeable integer, for example the polymer film, sheet or membrane of a two-phase system, such as an dialysis unit.
  • a cleansing fluid for example the polymer film, sheet or membrane of a two-phase system, such as an dialysis unit.
  • a selectively permeable integer for example the polymer film, sheet or membrane of a two-phase system, such as an dialysis unit.
  • the prime purpose of such tubes is to convey fluid irrigant and exudate through the length of the apparatus flow path, rather than to act as pressure vessels.
  • the tube walls may suitably be at least 25 micron thick.
  • the bore or any perforations, apertures, holes, openings, orifices, slits or slots along the pipes, etc. or in the hollow body or each of the hollow bodies may be of small cross-dimension.
  • the whole length of the apparatus for aspirating, irrigating and/or cleansing wounds should be microbe-impermeable once the wound dressing is over the wound in use.
  • wound dressing and the interior of the apparatus for aspirating, irrigating and/or cleansing wounds of the present invention is sterile.
  • the fluid may be sterilised in the fluid reservoir and/or the rest of the system in which the fluid recirculates, including the means for fluid cleansing, by ultraviolet, gamma or electron beam irradiation. This way, in particular reduces or eliminates contact of internal surfaces and the fluid with any sterilising agent.
  • Examples of other methods of sterilisation of the fluid also include e.g. the use of ultrafiltration through microapertures or micropores, e.g. of 0.22 to 0.45 micron maximum cross-dimension, to be selectively impermeable to microbes; and fluid antiseptics, such as solutions of chemicals, such as chlorhexidine and povidone iodine; metal ion sources, such as silver salts, e.g. silver nitrate; and hydrogen peroxide; although the latter involve contact of internal surfaces and the fluid with the sterilising agent.
  • fluid antiseptics such as solutions of chemicals, such as chlorhexidine and povidone iodine
  • metal ion sources such as silver salts, e.g. silver nitrate
  • hydrogen peroxide although the latter involve contact of internal surfaces and the fluid with the sterilising agent.
  • the interior of the wound dressing, the rest of the system in which the fluid recirculates, and/or the wound bed, even for a wound in a highly exuding. state are kept sterile after the fluid is sterilised in the fluid reservoir, or that at least naturally occurring microbial growth is inhibited.
  • materials that are potentially or actually beneficial in this respect may be added to the irrigant initially, and as desired the amount in recirculation increased by continuing addition.
  • antibacterial agents examples of such materials include antibacterial agents (some of which are listed above), and antifungal agents.
  • triclosan for example triclosan, iodine, metronidazole, cetrimide, chlorhexidine acetate, sodium undecylenate, chlorhexidine and iodine.
  • Buffering agents such as potassium dihydrogen phosphate/ disodium hydrogen phosphate
  • local analgesics/anaesthetics such as lidocaine/lignocaine hydrochloride, xylocaine (adrenoline, lidocaine) and/or anti-inflammatories, to reduce wound pain or inflammation or pain associated with the dressing.
  • physiologically active components of the exudate that are beneficial to wound healing are not removed before or after the application of fluid cleansing. This may occur, e.g. by the passive deposition of materials that are beneficial in promoting wound healing, such as proteins, e.g. growth factors. This may occur at any point at least one inlet or outlet pipe through at least one aperture, hole, opening, orifice, slit or slot.
  • the fluid contained in the hollow body may the deposition of materials that are beneficial in promoting wound healing, and consequent coating, a) may be added to the irrigant initially, and as desired the amount in recirculation increased by continuing addition, or b) may be used at any point or on any integer in the recirculation path in direct contact with the fluid, e.g. on the means for fluid cleansing or any desired tube or pipe.
  • coating materials for surfaces over which the circulating fluid passes include anticoagulants, such as heparin, and high surface tension materials, such as PTFE, and polyamides, which are useful for growth factors, enzymes and other proteins and derivatives.
  • the apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for admitting fluids directly or indirectly to the wound under the wound dressing in the form of a fluid supply tube to a fluid reservoir.
  • the fluid reservoir may be of any conventional type, e.g. a tube, bag (such as a bag typically used for blood or blood products, e.g. plasma, or for infusion feeds, e.g. of nutrients), chamber, pouch or other structure, e.g. of polymer film, which can contain the irrigant fluid.
  • a tube such as a bag typically used for blood or blood products, e.g. plasma, or for infusion feeds, e.g. of nutrients
  • chamber e.g. of polymer film, which can contain the irrigant fluid.
  • the reservoir may be made of a film, sheet or membrane, often with a (generally uniform) thickness similar to that of films or sheets used in conventional wound dressing backing layers.
  • up to 100 micron preferably up to 50 micron, more preferably up to 25 micron, and of 10 micron minimum thickness.
  • the type and material of the tubes throughout the apparatus of the invention for aspirating, irrigating and/or cleansing wounds and the fluid reservoir will be largely determined by their function.
  • the material should be non-toxic and biocompatible, inert to any active components, as appropriate of the irrigant from the fluid reservoir and/or wound exudate in the apparatus flow path, and, in any use of a two-phase system dialysis unit, of the dialysate that moves into the circulating fluid in the apparatus.
  • suitable materials for the fluid reservoir include synthetic polymeric materials, such as polyolefins, such as polyethylene, e.g. high- density polyethylene and polypropylene.
  • Suitable materials for the present purpose also include copolymers thereof, for example with vinyl acetate and mixtures thereof. Suitable materials for the present purpose further include medical grade poly(vinyl chloride).
  • the fluid reservoir will often have a stiff area to resist any substantial play between it and components that are not mutually integral, such as the fluid supply tube towards the wound dressing, and may be stiffened, reinforced or otherwise strengthened, e.g. by a projecting boss.
  • the device for moving fluid through the wound and means for fluid cleansing may be any appropriate for this purpose, and may act at any appropriate point for this purpose.
  • the means for fluid cleansing is (most appropriately for its purpose) downstream of the wound dressing, and provides the highest resistance in the flow path. This is especially the case where the means for fluid cleansing is a single- phase system, e.g. with ultrafiltration through microapertures or micropores, thus enhancing applied positive pressure to the wound.
  • the device When the device is applied to the fluid in recirculation in the fluid recirculation tube and/or the fluid in the fluid offtake tube downstream of and away from the wound dressing, it will usually apply negative pressure (i.e. below-atmospheric pressure or vacuum) to the wound bed.
  • negative pressure i.e. below-atmospheric pressure or vacuum
  • the means for fluid cleansing is (most appropriately for its purpose) downstream of the wound dressing, and provides the highest resistance in the flow path, thus enhancing applied negative pressure to the wound.
  • reciprocating pumps such as: shuttle pumps - with an oscillating shuttle mechanism to move fluids at rates from 2 to 50 ml per minute; diaphragm pumps - where pulsations of one or two flexible diaphragms displace liquid while check valves control the direction of the fluid flow, piston pumps - where pistons pump fluids through check valves, in particular for positive and/or negative pressure on the wound bed;
  • the outlet can be restricted without damaging the pump.
  • the type and/or capacity of the device will be largely determined by a) the appropriate or desired fluid volume flow rate of irrigant and/or wound exudate from the wound, and b) whether it is appropriate or desired to apply a positive or negative pressure to the wound bed, and the level of such pressure to the wound bed for optimum performance of the wound healing process, and by factors such as portability, power consumption and isolation from contamination.
  • Such a device may also suitably be one that is capable of slow-pulsed, continuous, variable, reversible and/or automated and/or programmable fluid movement. It may in particular be a pump of any of these types.
  • the circulating fluid from the wound will typically contain a preponderance of irrigant over wound exudate in recirculation from the fluid reservoir.
  • the type and/or capacity of the device will thus be largely determined in this respect by the appropriate or desired fluid volume flow rate of irrigant, rather than that of exudate, from the wound.
  • such a rate of flow of total irrigant and/or wound exudate will be of the order of 1 to 1000, e.g. 3 to 300, and less preferably 1 to 10 ml / cm 2 / 24 hour, where the cm 2 refers to the wound area.
  • the volume of irrigant and/or wound exudate in recirculation may vary over a wide range, but will typically be e.g. 1 to 8 I. (for example for large torso wounds), 200 to 1500 ml (for example for axillary and inguinal wounds), and 0.3 to 300 ml for limb wounds when the therapy is applied in this way.
  • suitable pressures are of the order of up to 25% atm such as up to 10% atm. positive or negative pressure on the wound bed, the apparatus being operated as a closed recirculating system.
  • the lower end is potentially more suitable for home use, where relatively high % pressures and/or vacua cannot be used safely without professional supervision, or for field hospital use.
  • the device may be a peristaltic pump or diaphragm pump, e.g. preferably a small portable diaphragm or peristaltic pump. These are preferred types of pump, in order in particular to reduce or eliminate contact of internal surfaces and moving parts of the pump with (chronic) wound exudate, and for ease of cleaning.
  • a preferred pump when the applied pressure is positive is a peristaltic pump, e.g. a small, portable peristaltic pump, mounted upstream of the means for fluid cleansing.
  • the pump is a peristaltic pump
  • this may be e.g. an Instech Model P720 miniature peristaltic pump, with a flow rate: of 0.2 - 180ml/hr and a weight of ⁇ 0.5 k. This is potentially useful for home and field hospital use.
  • the pump is a peristaltic pump
  • this may be e.g. an Instech Model P720 miniature peristaltic pump, with a flow rate: of 0.2 - 180ml/hr and a weight of ⁇ 0.5 k. This is potentially useful for home and field hospital use.
  • the pump may suitably be one that applies negative pressure to the wound and/or the means for fluid cleansing.
  • a preferred pump when the applied pressure is negative is a diaphragm pump, e.g. a small, portable diaphragm pump, mounted downstream of the dressing or the means for fluid cleansing.
  • the one or two flexible diaphragms that displace liquid may each be, for example a polymer film, sheet or membrane, that is connected to means for creating the pulsations.
  • This may be provided in any form that is convenient, inter alia as a piezoelectric transducer, a core of a solenoid or a ferromagnetic integer and coil in which the direction of current flow alternates, a rotary cam and follower, and so on.
  • the outlet from the dressing passes to the means for fluid cleansing for removal of materials deleterious to wound healing from wound exudate, and in turn to the fluid recirculation tube(s).
  • the apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for fluid cleansing, which may be a) a single-phase system, such as an ultrafiltration unit, or a chemical adsorption unit; or b) a two-phase system, such as a dialysis unit, or a biphasic extraction unit.
  • means for fluid cleansing may be a) a single-phase system, such as an ultrafiltration unit, or a chemical adsorption unit; or b) a two-phase system, such as a dialysis unit, or a biphasic extraction unit.
  • the single-phase system may be of any conventional type.
  • Examples of the means for fluid cleansing in such a system include a macro- or microfiltration unit, which appropriately comprises one or more macroscopic and/or microscopic filters.
  • the cleansing integer is a filter for materials deleterious to wound healing, for example a high throughput, low protein-binding polymer film, sheet or membrane which is selectively impermeable to materials deleterious to wound healing, which are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing is passed by it.
  • the cleansing integer is a filter for materials deleterious to wound healing, for example a high throughput, low protein-binding polymer film, sheet or membrane which is selectively impermeable to materials deleterious to wound healing, which are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing is passed by it.
  • the membrane may preferably be of a hydrophilic polymeric material, such as a cellulose acetate - nitrate mixture, polyvinylidene chloride, and, for example hydrophilic polyurethane.
  • a hydrophilic polymeric material such as a cellulose acetate - nitrate mixture, polyvinylidene chloride, and, for example hydrophilic polyurethane.
  • hydrophobic materials also including polyesters, such as polycarbonates, PTFE, and polyamides, e.g. 6- 6 and 6 - 10, and hydrophobic polyurethanes, and quartz and glass fibre.
  • microapertures or micropores the maximum cross-dimension of which will largely depend on the species that are to be selectively removed in this way and those to which it is to be permeable.
  • the former may be removed with microapertures or micropores, e.g. typically with a maximum cross-dimension in the range of 20 to 700 micron, e.g. 20 to 50 nm (for example for undesired proteins), 50 to 100 nm, 100 to 250 nm, 250 to 500 nm and 500 to 700 nm.
  • the filter integer may be a flat sheet or a membrane of a polymeric material in a more convoluted form, e.g. in the form of elongate structure, such as pipes, tubules, etc.
  • the system may be a chemical absorption and/or adsorption unit, for example one in which a particulate, such as a zeolite, or a layer, e.g. of a functionalised polymer has sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them.
  • a particulate such as a zeolite
  • a layer e.g. of a functionalised polymer has sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them.
  • the materials may be removed, e.g. by destroying or binding the materials that are deleterious to wound healing, by, for example chelators and/or ion exchangers, degraders, which may be enzymes.
  • Examples of such also include less specific chemical absorption and/or adsorption units, for example one in which a physical absorbent, such as activated carbon or a zeolite, has non-specific sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them.
  • a physical absorbent such as activated carbon or a zeolite
  • the cleansing integer for example the polymer film, sheet or other chemical absorption and/or adsorption means, etc should of course be capable of removing materials deleterious to wound healing at a practical rate for a given capacity of the apparatus flow path and the flow rate of irrigant.
  • the second fluid phase is (usually) a liquid that is immiscible with the circulating fluid from the dressing, over a surface of which the circulating fluid passes in direct contact with the cleansing fluid.
  • Materials deleterious to wound healing are removed into the dialysate, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
  • Examples of such means for fluid cleansing include those wherein the second fluid (dialysate) phase is perfluorodecalin and like materials
  • the two fluids recirculation fluid and dialysate
  • a significantly two- dimensional integer for example a polymer film, sheet or membrane or hollow fibre or filament that is permeable to materials in the circulating fluid in the apparatus.
  • the dialysate moves past the circulating fluid in the apparatus in a co- or preferably counter-current direction.
  • Pumps such as peristaltic pumps, and/or valves control the direction of the two fluid flows.
  • the cleansing fluid may less usually be static, although this may not provide a system with sufficient (dynamic) surface area to remove materials deleterious to wound healing from wound exudate at a practical rate.
  • Typical dialysate flow rates in a dialytic means for fluid cleansing in the present apparatus for aspirating, irrigating and/or cleansing wounds are those used in the conventional type of two-phase system, such as a dialysis unit for systemic therapy.
  • the integer may be a film, sheet or membrane, often of the same type, and of the same (generally uniform) thickness, as those used in conventional two- phase system, such as a dialysis unit for systemic therapy.
  • the film, sheet or membrane may be substantially flat, and depending on any pressure differential across it may require other materials on or in it to stiffen, reinforce or otherwise strengthen it.
  • This may be in the form of elongate structures, such as pipes, tubes hollow fibres or filaments or tubules of a round cross-section, e.g. elliptical or circular, e.g. in a parallel array with spaces therebetween.
  • the wound irrigant and/or wound exudate may recirculate through the inside and the cleansing fluid may pass into the spaces between adjacent pipes, tubes or tubules in a co- or preferably counter-current direction, or vice versa.
  • the means for fluid cleansing is a two-phase system, e.g. in the form of a dialysis unit, or a biphasic extraction unit
  • the circulating fluid from the wound and the fluid reservoir passes across one surfaces of a significantly two-dimensional integer, for example a polymer film, sheet or membrane which is selectively permeable to materials deleterious to wound healing. These are removed by passing a cleansing fluid across the other surface of the integer.
  • the integer may be a film, sheet or membrane that is selectively permeable to the foregoing materials deleterious to wound healing.
  • oxidants such as free radicals, e.g. peroxide and superoxide; iron II and iron III; all involved in oxidative stress on the wound bed; proteases, such as serine proteases, e.g. elastase, trypsin; chymotrypsin and thrombin; cysteine protease inhibitors; matrix metalloproteases, e.g. collagenase; and carboxyl (acid) proteases; endotoxins, such as lipopolysaccharides; autoinducer signalling molecules, such as homoserine lactone derivatives, e.g.
  • oxidants such as free radicals, e.g. peroxide and superoxide; iron II and iron III; all involved in oxidative stress on the wound bed
  • proteases such as serine proteases, e.g. elastase, trypsin; chymotrypsin and thrombin
  • cysteine protease inhibitors
  • oxo-alkyl derivatives oxo-alkyl derivatives
  • inhibitors of angiogenesis such as thrombospondin-1 (TSP-1), plasminogen activator inhibitor, or angiostatin (plasminogen fragment); pro-inflammatory cytokines such as tumour necrosis factor alpha (TNF ⁇ ) and interleukin 1 beta (IL-1 ⁇ ); and inflammatories, such as lipopolysaccharides, and e.g. histamine.
  • suitable materials for the film, sheet or membrane include natural and synthetic polymeric materials.
  • the membrane may be of one or more hydrophilic polymeric materials, such as a cellulose derivative, e.g. regenerated cellulose, a cellulose mono-, di- or tri- esters, such as cellulose mono-, di- or tri-acetate, benzyl cellulose and Hemophan, and mixtures thereof.
  • a cellulose derivative e.g. regenerated cellulose
  • a cellulose mono-, di- or tri- esters such as cellulose mono-, di- or tri-acetate, benzyl cellulose and Hemophan, and mixtures thereof.
  • Examples of other materials include hydrophobic materials, such as aromatic polysulphones, polyethersulphones, polyetherether-sulphones, polyketones, polyetherketones and polyetherether-ketones, and sulphonated derivatives thereof, and mixtures thereof.
  • Examples of other materials include hydrophobic materials, such as polyesters, such as polycarbonates and polyamides, e.g. 6-6 and 6 - 10; polyacrylates, including, e.g. poly(methyl methacrylate), polyacrylonitrile and copolymers thereof, for example acrylonitrile - sodium metallosulphonate copolymers; and poly(vinylidene chloride).
  • Suitable materials for the present membranes include thermoplastic polyolefins, such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof.
  • thermoplastic polyolefins such as polyethylene e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and polyvinyl alcohol, and mixtures thereof.
  • the dialysis membrane should have a molecular weight cut off (MWCO) chosen to allow selective perfusion of species deleterious to wound healing that have been targeted for removal from the wound.
  • MWCO molecular weight cut off
  • perfusion of the serine protease elastase would require a membrane with MWCO >25900 Dalton.
  • the MWCO threshold can be varied to suit each application between 1 and 3000000 Dalton.
  • the MWCO should be as close as possible to this weight to exclude interference by larger competitor species.
  • such a membrane with MWCO >25900 Dalton does not allow any significant amounts of the antagonist to elastase, alpha-1-antitrypsin (AAT) (molecular weight 54000 Dalton), which occurs naturally in wounds, to diffuse freely out of the wound fluid into the dialysate.
  • AAT alpha-1-antitrypsin
  • the inhibitor which is beneficial in promoting chronic wound healing, remains in contact with the wound bed, and can act beneficially on it, whilst the elastase that is deleterious to wound healing is removed.
  • Such use of the present apparatus is, e.g. favourable to the wound healing process in chronic wounds, such as diabetic foot ulcers, and especially decubitus pressure ulcers.
  • antagonists for example degrading enzymes, or sequestrating agents for elastase on the dialysate side of the membrane, may be used to enhance the removal of this protease from wound exudate.
  • antagonists for example degrading enzymes, or sequestrating agents for elastase on the dialysate side of the membrane, may be used to enhance the removal of this protease from wound exudate.
  • any such system is a conventional automated, programmable system which can cleanse the wound irrigant and/or wound exudate with minimal supervision.
  • fluid passes from a cleansing fluid through a selectively permeable integer.
  • This may be the typical permeable polymer film, sheet or membrane of a two- phase system, such as a dialysis unit.
  • solutes or disperse phase species will pass from the dialysate into the irrigant and/or wound exudate through the dialysis polymer film, sheet or membrane.
  • This property may be used to perfuse materials beneficial to wound healing into the irrigant and/or exudate from a dialysate.
  • ionic species such as bicarbonate
  • vitamins such as ascorbic acid (vitamin C) and vitamin E, and stable derivatives thereof, and mixtures thereof; to relieve oxidative stress on the wound bed
  • pH buffering agents such as potassium dihydrogen phosphate/ disodium hydrogen phosphate
  • local analgesics/anaesthetics such as lidocaine/lignocaine hydrochloride and xylocaine (adrenoline lidocaine) and/or anti-inflammatories, to reduce wound pain or inflammation or pain associated with the dressing nutrients to aid proliferation of wound cells, such as amino acids, sugars, low molecular weight tissue building blocks and trace elements; and other cell culture medium species
  • gases such as air, nitrogen, oxygen and/or nitric oxide.
  • both the single-phase system and two-phase system may have captive (non- labile, insoluble and/or immobilised) species such as the following, bound to an insoluble and/or immobilised substrate.
  • the irrigant and/or wound exudate from the wound dressing passes over and/or through these materials and then in turn to the fluid recirculation tube(s).
  • antioxidants and free radical scavengers such as 3-hydroxytyramine (dopamine), ascorbic acid (vitamin C), vitamin E and glutathione, and stable derivatives thereof, and mixtures thereof; to relieve oxidative stress on the wound bed; metal ion chelators and/or ion exchangers, such as transition metal ion chelators, such as iron III chelators (Fe III is involved in oxidative stress on the wound bed.), such as desferrioxamine (DFO), 3-hydroxytyramine (dopamine); iron III reductants; protease inhibitors, such as TIMPs and alpha 1-antitrypsin (AAT); serine protease inhibitors, such as 4-(2-aminoethyl)-benzene sulphonyl fluoride (AEBSF, PefaBloc) and N ⁇ -p-tosyl-L-lysine chloro-methyl ketone (TLCK) and ⁇ -amin
  • Suitable chelators and/or ion exchangers, degraders which may be enzymes, or other species.
  • the following types of functionalised substrate has sites on its surface that are capable of removing materials deleterious to wound healing on passing the circulating fluid from the wound and the fluid reservoir over them: heterogeneous resins , for example silica-supported reagents such as: metal scavengers,
  • the means for fluid cleansing may additionally, where appropriate, comprise one or more macroscopic and/or microscopic filters.
  • a less conventional type of two-phase system such as a dialysis unit, may be used as the means for fluid cleansing.
  • the dialysis polymer film, sheet or membrane is not an integer selectively permeable to materials deleterious to wound healing, such as proteases, such as serine proteases, e.g. elastase, trypsin; chymotrypsin and thrombin; cysteine protease inhibitors; matrix metalloproteases, e.g.
  • collagenase and carboxyl (acid) proteases
  • endotoxins such as lipopolysaccharides
  • inhibitors of angiogenesis such as thrombospondin-1 (TSP-1), Plasminogen activator inhibitor, or angiostatin (plasminogen fragment)
  • pro-inflammatory cytokines such as tumour necrosis factor alpha (TNF ⁇ ) and interleukin 1 beta (IL-1 ⁇ )
  • oxidants such as free radicals, e.g. , e.g. peroxide and superoxide
  • metal ions e.g. iron II and iron III; all involved in oxidative stress on the wound bed.
  • the dialysate or preferably in one or more solid structural integers with at least one surface in contact with the dialysate, in the means for fluid cleansing, there are one or more materials that can remove materials deleterious to wound healing from wound exudate, by being antagonists to such species, for example enzymes or others, such as protease inhibitors, such as serine protease inhibitors, such as 4-(2- aminoethyl)-benzene sulphonyl fluoride (AEBSF, PefaBloc) and N ⁇ -p-tosyl- L-lysine chloromethyl ketone (TLCK) and ⁇ -aminocaproyl-p- chlorobenzylamide; cysteine protease inhibitors; matrix metalloprotease inhibitors; and carboxyl (acid) protease inhibitors; binders and/or degraders, such as anti-inflammatory materials to bind or destroy lipopolysaccharides, e.g.
  • protease inhibitors such as se
  • anti-oxidants such as 3-hydroxytyramine (dopamine), ascorbic acid (vitamin C), vitamin E and glutathione, and stable derivatives thereof, and mixtures thereof; to relieve oxidative stress on the wound bed; chelators and/or ion exchanges, such as desferrioxamine (DFO), 3- hydroxytyramine (dopamine);
  • peptides including cytokines, e.g. bacterial cytokines, such as ⁇ -amino- ⁇ -butyrolactone and L-homocamosine); and sacrificial redox materials that are potentially or actually beneficial in promoting wound healing, such as iron III reductants; regeneratable materials of this type, such as glutathione redox systems; and other physiologically active components.
  • cytokines e.g. bacterial cytokines, such as ⁇ -amino- ⁇ -butyrolactone and L-homocamosine
  • sacrificial redox materials that are potentially or actually beneficial in promoting wound healing, such as iron III reductants
  • regeneratable materials of this type such as glutathione redox systems
  • other physiologically active components include peptides (including cytokines, e.g. bacterial cytokines, such as ⁇ -amino- ⁇ -butyrolactone and L-homocamosine); and sa
  • Some (mainly ionic) species will pass from the dialysate into the irrigant and/or wound exudate through the dialysis polymer film, sheet or membrane that is not very selectively permeable to materials deleterious to wound healing.
  • the components of the exudate from a wound and/or irrigant fluid will diffuse freely to and fro through it.
  • the target materials deleterious to wound healing also pass into the dialysate from the exudate through the dialysis polymer film, sheet or membrane that is not very selectively permeable to materials deleterious to wound healing.
  • the target materials deleterious to wound healing come into contact with the dialysate, or preferably with one or more solid structural integers with at least one surface in the dialysate, and are removed by the appropriate antagonists, binders and/or degraders, chelators and/or ion exchangers and redox agents, etc.
  • the cleansed fluid still containing some materials that are beneficial in promoting wound healing, is returned to the recirculation tube.
  • the target materials are constantly removed from the dialysate, very little of these species will pass from the dialysate into the irrigant and/or wound exudate, and a steady state concentration equilibrium is not set up, even if the species are constantly 'topped up' from the wound dressing. It is believed that circulating wound fluid aids in removal from recirculation of the materials deleterious to wound healing from wound exudate, whilst retaining materials that are beneficial in promoting wound healing in contact with the wound.
  • a particular advantage of this form of the two-phase system is that where a material that can remove materials deleterious to wound healing from wound exudate is (cyto)toxic or bioincompatible, or not inert to any components that are beneficial in promoting wound healing, the system does not allow any significant amounts of antagonist to diffuse freely out of the dialysate into the irrigant fluid.
  • the active material can act beneficially on the fluid however.
  • the film sheet or membrane is preferably a dialysis membrane of molecular weight cut off (MWCO) (as conventionally defined) chosen to allow perfusion of species targeted for sequestration or destruction.
  • MWCO molecular weight cut off
  • sequestration of the serine protease elastase would require a membrane with MWCO >25900 Dalton.
  • the MWCO threshold can be varied to suit each application between 1 and
  • the MWCO should be as close as possible to this weight to exclude sequestering interference by larger competitor species.
  • Both the single-phase system, such as an ultrafiltration unit, and two-phase system, such as a dialysis unit, may be in modular form that is relatively easily demountable from the apparatus of the invention.
  • the system may suitably comprise one or more such modules.
  • the means in the form of a two-phase system, such as an dialysis unit
  • the apparatus of the invention for aspirating, irrigating and/or cleansing wounds is provided with means for bleeding the offtake and/or recirculation tubes, such as a regulator, such as a valve or other control device for bleeding fluids from the wound.
  • a regulator such as a valve or other control device for bleeding fluids from the wound.
  • the device for moving fluid through the wound and means for fluid cleansing is used to move irrigant to the wound dressing and apply the desired positive or negative pressure on the wound bed.
  • the desired balance of fluid in recirculation tube will typically be regulated by means of a) the means for bleeding the offtake and/or recirculation tubes, b) the means for flow switching between supply and recirculation, and/or c) the means for moving fluid over the wound bed and through the means for fluid cleansing, as appropriate.
  • the apparatus for aspirating, irrigating and/or cleansing wounds is a single-phase system, such as an ultrafiltration unit, b) the wound is not in a highly exuding state and c) it is not appropriate or desired to admit fluid into the wound from the fluid reservoir, there is no or negligible change in the balance of fluid in recirculation.
  • the apparatus may be operated as a closed recirculating system.
  • the means for flow switching between supply and recirculation tubes is set to close the wound to the fluid reservoir via the fluid supply tube, and the means for bleeding the offtake and/or recirculation tubes are also closed.
  • the apparatus for aspirating, irrigating and/or cleansing wounds is a single-phase system, such as an ultrafiltration unit, b) the wound is in a highly exuding state and/or c) it is appropriate or desired to admit fluid into the wound from the fluid reservoir, there is a positive change in the balance of fluid in recirculation.
  • the apparatus Once it has been primed throughout, e.g. to the desired positive or negative pressure on the wound bed, the apparatus cannot be operated as a closed recirculating system, without the pressure to the wound bed increasing, possibly undesirably.
  • the means for bleeding the offtake and/or recirculation tubes must be opened to some extent to relieve positive pressure on the wound bed.
  • the bleed-off may be voided to waste, e.g. to a collection bag. Materials that are beneficial in promoting wound healing may be lost to the site where they can be potentially of most benefit, i.e. the wound bed, when the therapy is applied in this way.
  • the outlet from the means for bleeding the offtake and/or recirculation tubes may be collected and monitored and used to diagnose the status of the wound and/or its exudate.
  • the waste reservoir may be of any conventional type, e.g. a tube, bag (such as a bag typically used as an ostomy bag), chamber, pouch or other structure, e.g. of polymer film, which can contain the irrigant fluid that has been bled off.
  • the type and material of the waste reservoir will be largely determined by its function. To be suitable for use, the material need only be fluid-impermeable once in use, and flexible.
  • suitable materials for the fluid reservoir include synthetic polymeric materials, such as polyolefins, such as poly (vinylidene chloride).
  • suitable materials for the present purpose also include polyethylene, e.g. high-density polyethylene, polypropylene, copolymers thereof, for example with vinyl acetate and mixtures thereof.
  • a conformable wound dressing characterised in that it comprises a backing layer with a wound-facing face which is capable of forming a relatively fluid-tight seal or closure over a wound and has at least one inlet pipe for connection to a fluid supply tube, which passes through and/or under the wound-facing face, and at least one outlet pipe for connection to a fluid offtake tube, which passes through and/or under the wound-facing face, the point at which the or each inlet pipe and the or each outlet pipe passes through and/or under the wound-facing face forming a relatively fluid-tight seal or closure over the wound.
  • the dressing is advantageously provided for use in a bacteria-proof pouch.
  • a third aspect of the present invention there is provided a method of treating wounds to promote wound healing using the apparatus for aspirating, irrigating and/or cleansing wounds of the present invention.
  • Figure 1 is a schematic view of an apparatus for aspirating, irrigating and/or cleansing a wound according to the first aspect of the present invention. It has a single-phase system means for fluid cleansing in the form of an ultrafiltration unit.
  • Figure 2 is a schematic view of an apparatus for aspirating, irrigating and/or cleansing a wound according to the first aspect of the present invention. It has a two-phase system means for fluid cleansing in the form of a dialysis unit, or a biphasic extraction unit.
  • any sonode or sonode-transducer is omitted for clarity.
  • Figures 3 to 8 are cross-sectional views of conformable wound dressings, of the second aspect of the present invention for aspirating and/or irrigating wounds.
  • Figure 9 is a schematic view of an apparatus for aspirating, irrigating and/or cleansing a wound according to the first aspect of the present invention. It has a single-phase system means for fluid cleansing in the form of an ultrafiltration unit.
  • Figure 10 is a schematic view of an apparatus for aspirating, irrigating and/or cleansing a wound according to the first aspect of the present invention. It has a two-phase system means for fluid cleansing in the form of a dialysis unit, or a biphasic extraction unit.
  • Figure 12 is a view of an apparatus used for the experimental work of Example 3.
  • the apparatus (1) for aspirating, irrigating and/or cleansing wounds comprises a conformable wound dressing (2), having a backing layer (3) which is capable of forming a relatively fluid-tight seal or closure (4) over a wound (5) and one inlet pipe (6) for connection to a fluid supply tube (7), which passes through the wound-facing face of the backing layer (3) at (8), and one outlet pipe (9) for connection to a fluid offtake tube (10), which passes through the wound-facing face at (11), the points (8), (11) at which the inlet pipe and the outlet pipe passes through and/or under the wound-facing face forming a relatively fluid-tight seal or closure over the wound, means for applying ultrasonic, energy to the wound bed, here a piezoelectric sonode-transducer (111) (not shown), connected to an ultrasonic frequency electrical signal generator run at the appropriate frequencies (112) (not shown).
  • a piezoelectric sonode-transducer 111
  • an ultrasonic frequency electrical signal generator run at the appropriate frequencies (1
  • the sonode-transducer ( 11) is mounted distally on the body on the dressing (2) at the fluid inlet pipe (6) where it passes through the wound-facing face of the backing layer (3).
  • the inlet pipe (6) is connected via means for flow switching between supply and recirculation, here a T- valve (14), by the fluid supply tube (7) to a fluid reservoir (12) and to a fluid recirculation tube (13) having a means for bleeding the tube, here a bleed T-valve (16) to waste, e.g. to a collection bag (not shown), the outlet pipe (9) being connected to a fluid offtake tube (10), connected in turn to means for fluid cleansing (17), here in the form of an ultrafiltration unit, connected to the inlet pipe (6) via the fluid recirculation tube (13) and T- valve (14), and a device for moving fluid through the wound and means for fluid cleansing (17), here a peristaltic pump (18), e.g. preferably a small portable peristaltic pump, acting on the fluid circulation tube (13) with the peripheral rollers on its rotor (not shown) to apply a low negative pressure on the wound.
  • a peristaltic pump e.g. preferably a small portable peristal
  • the ultrafiltration unit (17) is a single-phase system. In this the circulating fluid from the wound and the fluid reservoir passes through a self-contained system in which materials deleterious to wound healing are removed and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned via the recirculation tube to the wound bed.
  • inlet pipes (6) which are connected respectively to a fluid supply tube (7) and fluid recirculation tube (13), respectively having a first valve (19) for admitting fluid into the wound from the fluid reservoir (12) and a second valve (20) for admitting fluid into the wound from the recirculation tube.
  • first valve (19) for admitting fluid into the wound from the fluid reservoir (12)
  • second valve (20) for admitting fluid into the wound from the recirculation tube.
  • valve (16) is opened to a collection bag (not shown), and the T- valve (14) is turned to admit fluid from the fluid reservoir to the wound dressing through the fluid supply tube (7) and inlet pipe (6).
  • the pump (18) is started to nip the fluid recirculation tube (13) with the peripheral rollers on its rotor (not shown) to apply a low positive pressure on the wound. It is allowed to run until the apparatus is primed throughout the whole length of the apparatus flow path and excess fluid is voided to waste via the bleed T-valve (16) into the collection bag (not shown).
  • the T-valve (14) is then turned to switch from supply and recirculation, i.e. is set to close the wound to the fluid reservoir (12) but to admit fluid into the wound from the fluid recirculation tube (13), and the bleed T-valve (16) is simultaneously closed.
  • a recirculating system is then set up by opening the second valve (20) for admitting fluid into the wound from the recirculation tube (13).)
  • the circulating fluid from the wound and the fluid reservoir (12) passes through the ultrafiltration unit (17). Materials deleterious to wound healing are removed and the cleansed fluid still containing materials that are beneficial in promoting wound healing is returned via the recirculation tube (13) to the wound bed.
  • the ultrasonic frequency electrical signal generator (112) (not shown) is started and run at the appropriate frequency to drive the sonode-transducer (111). This may be continued as long as desired.
  • the recirculation of fluid may be continued as long as desired.
  • the ultrasonic frequency electrical signal generator (112) (not shown) is then stopped so that it ceases to drive the sonode-transducer (111).
  • the bleed valve (16) is simultaneously opened, so that fresh fluid flushes the recirculating system.
  • the running of the pump (18) may be continued until the apparatus is flushed, when it and the fluid recirculation is stopped.
  • the apparatus (21) is a variant of that of Figure 1 , with identical, and identically numbered, components, except for the means for fluid cleansing, which is in the form of a two-phase system, here a dialysis unit (23).
  • the dialysis unit (23) thus has an internal polymer film, sheet or membrane (24), selectively permeable to materials deleterious to wound healing, which divides it into a) a first chamber (25), through which passes a cleansing fluid across one surface of the polymer film, sheet or membrane, and b) a second chamber (26), through which passes the circulating fluid from the wound and the fluid reservoir (12), and from which deleterious materials are removed
  • the dialysis unit (23) thus has a dialysate inlet pipe (28) connecting to a dialysate supply tube (29) which passes to a peristaltic pump (38), e.g. preferably a small portable peristaltic pump, acting on the dialysate supply tube (29) with the peripheral rollers on its rotor (not shown) to supply cleansing fluid across the surface of the polymer film, sheet or membrane (24) in the first chamber (25) from a dialysate reservoir (not shown) via a valve (34).
  • the dialysis unit (23) also has a dialysate outlet pipe (30) connecting to a dialysate outlet tube (31) which passes to waste via a second bleed T-valve (36) into, e.g. a collection bag (not shown).
  • the pump (38) is started to nip fluid dialysate tube (29) with the peripheral rollers on its rotor (not shown) to pump cleansing fluid to the first chamber from a dialysate reservoir (not shown) and out to waste via the bleed valve (36) into the collection bag (not shown).
  • the ultrasonic frequency electrical signal generator (112) (not shown) is started and run at the appropriate frequency to drive the sonode-transducer (111). This may be continued as long as desired.
  • the dialysis unit (23) is a module (or scrubbing cartridge) with a substrate that changes colour to indicate the presence of detrimental factors in the cleansed fluid, and that the scrubbing cartridge is exhausted and should be renewed.
  • the dialysis unit has a first chamber (25), but one in which the cleansing fluid is static.
  • the device for moving fluid through the wound and means for fluid cleansing (17) in Figure 2 may optionally act on the fluid supply tube (7) as well as the fluid recirculation tube (13).
  • FIG. 3 a form of dressings for deeper wounds is shown.
  • This comprises a circular backing layer (342) and a chamber (363) in the form of a deeply indented disc much like a multiple Maltese cross.
  • This is defined by an upper impervious membrane (361) and a lower porous film (362) with apertures (364) that deliver the irrigant fluid directly from the wound bed over an extended area.
  • the chamber (363) is able to conform well to the wound bed by the arms closing in and possibly overlapping in insertion into the wound.
  • the space above the chamber (363) is filled with an elastically resilient foam or loose gauze.
  • a piezoelectric sonode-transducer (111) is mounted on the upper face of the backing layer (342), and is connected to an ultrasonic frequency electrical signal generator run at the appropriate frequencies (112) (shown schematically) by electrical leads (113).
  • a piezoelectric transducing polyolefin such as polyvinylidene fluoride and copolymers thereof
  • An inlet pipe (346) and outlet pipe (347) are mounted centrally in a boss (351) on the sonode-transducer (111) on the backing layer (342), and pass through both.
  • the inlet pipe (346) communicates with the interior of the chamber (348).
  • the outlet pipe (347) extends radially to just below the backing layer (342) to communicate with the interior of the pouch (363).
  • this form of the dressing is provided with a wound filler (348) under a circular backing layer (342).
  • the filler (348) comprises a generally downwardly domed toroidal conformable hollow body, defined by a membrane (349) which is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
  • the filler (348) is permanently attached to the backing layer via a boss (351), which is e.g. heat-sealed to the backing layer (342).
  • Preferred foam materials include reticulated filtration polyurethane foams with small apertures or pores.
  • a piezoelectric sonode-transducer (111) is mounted on the underside of the boss (351), and is connected to an ultrasonic frequency electrical signal generator run at the appropriate frequencies (112) (shown schematically) by electrical leads (113) running through the boss (351).
  • It is a sheet or membrane of a piezoelectric transducing polyolefin, such as polyvinylidene fluoride and copolymers thereof, and is adhered by heat lamination to the dressing.
  • a piezoelectric transducing polyolefin such as polyvinylidene fluoride and copolymers thereof
  • An inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) are mounted centrally in the boss (351) in the backing layer (342).
  • the inflation inlet pipe (350) communicates with the interior of the hollow body (348), to permit inflation of the body (348).
  • the inlet pipe (346) extends in a pipe (352) through boss (351).
  • the outlet pipe (347) extends radially immediately under the backing layer (342), and collects fluid flowing radially through the foam layer (364) from the wound periphery when the dressing is in use.
  • this form of the dressing is a variant of that of Figure 4, with identical, and identically numbered, components, except for the following:
  • a downwardly domed membrane (361) with apertures (362) is permanently attached at its periphery by heat-sealing to, and lies underneath, the filler (348), to form an inlet manifold (353).
  • the pipe (352) communicates with the interior of the inlet manifold (353), but not through the piezoelectric sonode- transducer (111). This is still mounted on the underside of the boss (351), but spaced from it by struts (372) defining peripheral channels or conduits (363) that communicate between the pipe (352) and the inlet manifold (353).
  • the dressing is also provided with a wound filler (348) under a circular backing layer (342).
  • This comprises a generally oblately spheroidal conformable hollow body, defined by a membrane (349) which is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
  • the filler (348) is permanently attached to the backing layer via a boss (351), which is e.g. heat-sealed to the backing layer (342).
  • An inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) are mounted centrally in the boss (351) in the backing layer (342) above the hollow body (348).
  • the inflation inlet pipe (350) communicates with the interior of the hollow body (348), to permit inflation of the body (348).
  • the inlet pipe (346) extends in a pipe (352) effectively through the hollow body (348).
  • the outlet pipe (347) extends radially immediately under the backing layer (342).
  • the lower end of the inlet pipe (346) is splayed into a funnel (356), in part of the wall of which is a recess (357).
  • a sonode-transducer, such as an Exogen TM device (111) is a tight push fit in the recess.
  • this form of the dressing is a variant of that of Figure 6, with identical, and identically numbered, components, except that the sonode-transducer, whilst mounted in the same overall position is not in a recess, but within the hollow body (348).
  • This form of the dressing is a more suitable layout for deeper wounds
  • FIG 8a another form for deeper wounds is shown.
  • This comprises a circular, or more usually square or rectangular backing layer (342) and a chamber (363) in the form of a deeply indented disc much like a multiple Maltese cross or a stylised rose.
  • FIG. 6 This is defined by an upper impervious membrane (361) and a lower porous film (362) with apertures (364) that deliver the irrigant fluid directly to the wound bed over an extended area, and thus effectively forms an inlet manifold.
  • Three configurations of the chamber (363) are shown in Figure 8b, all of which are able to conform well to the wound bed by the arms closing in and possibly overlapping in insertion into the wound.
  • a wound filler (348) under the backing layer (342) is filled with a wound filler (348) under the backing layer (342).
  • This comprises an oblately spheroidal conformable hollow body, defined by a membrane (349) that is filled with a fluid, here air or nitrogen, that urges it to the wound shape.
  • a piezoelectric sonode-transducer (111) is mounted on the upper face of the backing layer (342), and is connected to an ultrasonic frequency electrical signal generator run at the appropriate frequencies (112) (shown schematically) by electrical leads (113).
  • a piezoelectric transducing polyolefin such as polyvinylidene fluoride and copolymers thereof
  • a moulded hat-shaped boss (351) is mounted centrally on the upper impervious membrane (361) of the chamber (363). It has three internal channels, conduits or passages through it (not shown), each with entry and exit apertures.
  • the filler (348) is attached to the membrane (361) of the chamber (363) by adhesive, heat welding or a mechanical fixator, such as a cooperating pin and socket.
  • An inflation inlet pipe (350), inlet pipe (346) and outlet pipe (347) pass under the edge of the proximal face of the backing layer (342) of the dressing, and extend radially immediately under the filler (348) and over the membrane (361) of the chamber (363) to each mate with an entry aperture in the boss (351).
  • An exit to the internal channel, conduit or passage through it that receives the inflation inlet pipe (350) communicates with the interior of the hollow filler (348), to permit inflation.
  • An exit to the internal channel, conduit or passage that receives the inlet pipe (346) communicates with the interior of the chamber (363) to deliver the irrigant fluid via the chamber (363) to the wound bed over an extended area.
  • an exit to the internal channel, conduit or passage that receives the outlet pipe (347) communicates with the space above the chamber (363) and under the wound filler (348), and collects flow of irrigant and/or wound exudate radially from the wound periphery.
  • the apparatus (1) for aspirating, irrigating and/or cleansing wounds is a variant of the apparatus (1) of Figure 1.
  • An alternative to the by-pass (711) is a pressure sensor in the system that will detect excessive load or pressure, and shut down the pump.
  • the apparatus (1) for aspirating, irrigating and/or cleansing wounds is a variant of the apparatus (21) of Figure 2.
  • the latter is a two-phase system with a dialysis unit (21), but is one in which dialytic fluid passes only once across the surface of the dialytic membrane (24) in the first chamber (25) from a dialysate reservoir (not shown) to waste via a second bleed T-valve (816) into, e.g. a collection bag (not shown).
  • This variant has a dialysate recirculation tube (811) running between a first T- valve (816) on the inlet side of the dialysate pump (38) and a second T-valve (817) to permit the pump (38) to recirculate the dialysate once the circuit is primed in multiple passes through the dialysis unit (23).
  • the apparatus (1) for aspirating, irrigating and/or cleansing wounds is a major variant of the apparatus shown in Figure 1.
  • the device for moving fluid through the wound and means for fluid cleansing (17) in Figure 1 is a peristaltic pump (18), e.g. preferably a small portable peristaltic pump, acting on the fluid circulation tube (13) downstream of the dressing (2) to apply a low negative pressure on the wound.
  • a peristaltic pump e.g. preferably a small portable peristaltic pump, acting on the fluid circulation tube (13) downstream of the dressing (2) to apply a low negative pressure on the wound.
  • Example 1 The combination of the removal by dialysis of materials deleterious to wound healing (H 2 O 2 ) by an enzyme (catalase) retained in a static second phase and ultrasound waves.
  • An apparatus of the present invention was constructed essentially as in the variant of the apparatus of Figure 2, described above, i.e. one in which the means for fluid cleansing is a two-phase system dialysis unit, but with a static dialysate phase.
  • the means for fluid cleansing is a two-phase system dialysis unit, but with a static dialysate phase.
  • an irrigant and/or wound exudate first phase from the wound recirculates through a first circuit. It passes over a selectively permeable dialysis membrane that separates it from a static second fluid (dialysate) phase.
  • Hydrogen peroxide is produced in conditions of oxidative stress following reduced blood flow and or the inflammatory response to bacterial contamination of wounds. It may be removed by the appropriate antagonists and/or degraders, which include enzymic or other inhibitors, such as peroxide degraders, e.g. catalase.
  • the first circuit comprised a surrogate wound chamber (Minucells perfusion chamber) in which normal diploid human fibroblasts were cultured on 13 mm diameter (Thermanox polymer) cover slips retained in a two part support (Minucells Minusheets). Tissues present in the healing wound that must survive and proliferate were represented by the cells within the chamber.
  • a surrogate wound chamber Minucells perfusion chamber
  • 13 mm diameter Thermanox polymer
  • nutrient medium (DMEM with 5% FCS with 1% Buffer All) to simulate wound exudate was pumped from a reservoir into the lower aspect of the chamber where it bathed the fibroblasts and was removed from the upper aspect of the chamber and returned to the reservoir.
  • the first circuit also includes, upstream of the wound chamber, a static second phase dialysis unit, comprising a length of dialysis tubing (Pierce Snake skin 68100 CG 49358B, 10KD cut off) placed within the first circuit reservoir in which a static second phase second cleansing circuit containing nutrient media with between 5,000 and 50,000 units ( ⁇ moles H 2 O 2 degraded per min at pH7, 25°C) per ml of catalase (in a circuit with a reservoir and total volume of between 5.0 ml and 75 ml) at a flow rate of between 0.5 ml min "1 and 5.0 ml min "1 .
  • a static second phase dialysis unit comprising a length of dialysis tubing (Pierce Snake skin 68100 CG 49358B, 10KD cut off) placed within the first circuit reservoir in which a static second phase second cleansing circuit containing nutrient media with between 5,000 and 50,000 units ( ⁇ moles H 2 O 2 degraded per min at
  • the pump was a peristaltic pump acting on silicone (or equivalent) elastic tubing.
  • the internal diameter of the tubing was 1.0 mm.
  • a total volume for the first circuit including the chamber and the reservoir at a number of values between 25 and 75 ml was used.
  • the flow rates used were at a number of values between 0.5 ml min "1 and 5.0 ml min "1 .
  • An ultrasound signal was generated for 20 minutes with a high power driver, set at 100mW/cm 2 , driving standard transducers) was applied to the base of the Minucell chambers whilst media was flowing in the first circuit.
  • a control experiment is also conducted where ultrasound waves were omitted.
  • the fibroblasts survive and proliferate to a greater extent than in the control circuits.
  • Example 2 The combination of the removal by dialysis of materials deleterious to wound healing (H?O?) by an enzyme (catalase) retained in a moving second phase and ultrasound.
  • An apparatus of the present invention is constructed essentially as in Figure 2, i.e. one in which the means for fluid cleansing is a two-phase system dialysis unit.
  • the means for fluid cleansing is a two-phase system dialysis unit.
  • an irrigant and/or wound exudate first phase from the wound recirculates through a first circuit and passes in through the dialysis unit in contact across a selectively permeable dialysis membrane with a second fluid (dialysate) phase.
  • the dialysis unit is operated with the two phases flowing counter-current to each other.
  • Hydrogen peroxide is produced in conditions of oxidative stress following reduced blood flow and or the inflammatory response to bacterial contamination of wounds. It may be removed by the appropriate antagonists and/or degraders, which include enzymic or other inhibitors, such as peroxide degraders, e.g. catalase.
  • the first circuit comprises a surrogate wound chamber (Minucells perfusion chamber) in which normal diploid human fibroblasts are cultured on 13 mm diameter (Thermanox polymer) cover slips retained in a two-part support (Minucells Minusheets). Tissues present in the healing wound that must survive and proliferate are represented by the cells within the chamber. After overnight serum starvation nutrient medium (DMEM with 5%FCS with 1% Buffer All) to simulate wound exudate is pumped from a reservoir into the lower aspect of the chamber where it bathed the fibroblasts and is removed from the upper aspect of the chamber and returned to the reservoir.
  • DMEM serum starvation nutrient medium
  • the first circuit also comprises a) Upstream of the wound chamber, a luer-fitting hollow fibre tangential membrane dialysis unit (Spectrum® MicroKros® X14S-100-04N, 8 cm 2 surface area, 400KD Mol. Wt.
  • a luer-fitting hollow fibre tangential membrane dialysis unit Spectrum® MicroKros® X14S-100-04N, 8 cm 2 surface area, 400KD Mol. Wt.
  • a second cleansing circuit containing nutrient media with between 5,000 and 50,000 units ( ⁇ moles H 2 O 2 degraded per min at pH7, 25°C) per ml of catalase in a circuit with a reservoir and total volume of between 5.0 mL and 20 mL) at a flow rate of between 0.5 ml min "1 and 5.0 ml min "1 could be passed in a counter current direction, and b) ultrasound waves are delivered to the base of the Minucell chamber.
  • the pumps for the two circuits are peristaltic pumps acting on silicone tubing or equivalent.
  • the internal diameter of the tubing is 1.0 mm.
  • a total volume for the first circuit including the chamber and the reservoir at a number of values between 25 and 75 ml is used.
  • the flow rates used are at a number of values between 0.5 ml min "1 and 5.0 ml min "1 .
  • First and second control apparatus are also constructed essentially as in Figure 2, but where either a) the cleansing membrane dialysis unit is omitted, so that the nutrient flow passes directly from the reservoir, or b) the 20-minutes ultrasound signal is omitted.
  • the nutrient medium flow in the first circuit is a) connected into the ends of the membrane dialysis unit through which a second cleansing circuit containing catalase (at the concentrations and flow rates noted above) is passing in a counter current direction, and b) an ultrasound signal is generated for 20 minutes with a high power driver, set at 100mW/cm 2 , driving standard transducers) is applied to the base of the minucell chambers whilst media is flowing in the first circuit. the fibroblasts survive and proliferate to a greater extent during a 24 hour period than the control circuits.
  • Example 3 Demonstration of the presence of ultrasound at the base of a wound whilst the wound is subjected to simultaneous irrigation and aspiration at reduced pressure and ultrasound delivered through the backing layer of a wound dressing of the present invention.
  • the experimental set-up was as shown in Figure 12 in which an ultrasound detector assembly (801) with a detector (802) and a signal cable (811) was centrally placed, detector (802) uppermost, at the bottom of a Perspex wound model cavity (803) (130mm diameter top opening; 30mm depth), and fixed in a horizontal position using a block of adhesive putty.
  • a dressing inlet manifold (804) comprises an inlet chamber (805) defined by an upper impermeable layer (806) and a lower permeable layer (807) and an irrigant delivery tube (808) passing into an irrigant inlet (809).
  • the manifold (804) was placed on top of the detector assembly (801), and a wound filler (810) in the form of a block of reticulated polyurethane foam was placed on top of the manifold (804).
  • the irrigant delivery tube (808) to the manifold (804) and the cable (811) from the ultrasonic detector (802) were fed under the filler (810), and then through pre-formed channels in a polyurethane side port (812). Care was taken to keep the cable (811) and tube (808) from passing over the ultrasound detector (802).
  • the end of the irrigant delivery tube (808) furthest from the manifold (804) was connected to a peristaltic irrigant pump (817) (Ismatech IPC pump), in turn connected to an irrigant reservoir (818) (1000ml Schott Duran).
  • the end of the cable (811) furthest from the detector (802) was connected to an oscilloscope (819) (Tektronix TDS 3014).
  • An aspiration tube (813) also passes through the side port (812), but only extends into the wound cavity (803) a short distance, and was laid on top of the filler (810). The end of the aspiration tube (813) furthest from the cavity
  • the monitor was in turn connected via a pressure control valve (821) to a diaphragm vacuum pump (822) (Schwarz diaphragm vacuum pump and associated DC power supply (12V))
  • the side port (812) was bonded to the top of the wound model with an acrylic pressure sensitive adhesive.
  • An adhesive-coated Opsite film backing layer (814) was placed over the wound model to cover the cavity (803) and the side port (812).
  • additional pressure sensitive adhesive was placed around the tubes (808), (813) and cable (811) at the point where they left the side port (812).
  • An annular ultrasound transducer holder (815) was bonded to the upper surface of the Opsite backing layer (814) using unsupported pressure sensitive adhesive. A small blob of ultrasound coupling gel was placed on the film area encircled by the holder (815).
  • a cylindrical ultrasound transducer unit (816) (28mm diameter; 11mm depth) from a low intensity ultrasound source (Exogen 2000+ fracture healing system (Smith & Nephew) was connected to the ultrasound signal generator (824) from such a system.
  • the unit (816) provides low intensity ultrasound comparable to the diagnostic ultrasound intensities used in sonogram (foetal monitoring) procedures, and only 1% to 5% of the intensity used in conventional therapeutic ultrasound.
  • the unit (816) is dimensioned to mate with the holder (815) in a sliding push fit, and was pushed into the holder (815), at which point it was fully in contact with the coupling gel.
  • the peristaltic irrigant pump (817) was started to pump irrigant into the wound cavity (803). Once the cavity (803) was full, the irrigation pump was stopped, and the diaphragm pump (822) was started and negative pressure was established in the wound cavity (803) and held at 81.9mmHg below atmospheric pressure as monitored at the vacuum vessel (820).)
  • the ultrasonic signal generator (824) was set up and turned on such that the unit (816) provides low intensity ultrasound at a frequency of 1.5 ⁇ 5% MHz, with a modulating signal burst width of 200 + 10% microseconds at a repetition rate of 1.0 ⁇ 10% KHz (800 microsecond intervals) at a temporal average power of 117 ⁇ 30% mW,
  • a signal with the same signal burst width and repetition rate as that produced by the ultrasound generator was detected at the model wound bed.
  • the detected signal strength gradually increased as the top film was drawn down into the model wound by the applied negative pressure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Sustainable Development (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Un appareil de nettoyage de blessures doté d'un module d'application d'une haute fréquence vibratoire, plus particulièrement une énergie ultrasonore sur le lit blessé dans lequel un fluide d'irrigation provenant d'un réservoir relié et à un pansement adaptable et à un exsudat à partir du pansement sont recirculés par un dispositif en vue du déplacement du fluide à travers un itinéraire traversant le pansement et un module de nettoyage fluide et de retour au pansement. Le module de nettoyage (qui peut être un système à phase simple, notamment de microfiltration ou un système à double phase, notamment un système dyalétique) élimine les substances délétères afin d'assurer la cicatrisation d'une blessure, et le fluide nettoyé, contenant encore les substances bénéfiques à la cicatrisation d'une blessure, revient sur le lit blessé. Le module d'application d'une haute fréquence vibratoire, notamment une énergie ultrasonore sur le lit blessé favorise la cicatrisation. Le pansement et une méthode de traitement utilisant l'appareil font également l'objet de cette invention.
PCT/GB2005/001584 2004-04-27 2005-04-26 Appareil de nettoyage de blessures a ultrasons WO2005105175A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0409292.0 2004-04-27
GBGB0409292.0A GB0409292D0 (en) 2004-04-27 2004-04-27 Apparatus with ultrasound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006238957A Division AU2006238957B2 (en) 2004-04-27 2006-04-27 Wound treating apparatus and method

Publications (1)

Publication Number Publication Date
WO2005105175A1 true WO2005105175A1 (fr) 2005-11-10

Family

ID=32408060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/001584 WO2005105175A1 (fr) 2004-04-27 2005-04-26 Appareil de nettoyage de blessures a ultrasons

Country Status (2)

Country Link
GB (1) GB0409292D0 (fr)
WO (1) WO2005105175A1 (fr)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114648A2 (fr) * 2005-04-27 2006-11-02 Smith & Nephew, Plc Dispositif et procede pour le traitement de blessure
WO2006114638A2 (fr) * 2005-04-27 2006-11-02 Smith & Nephew, Plc Appareil et methode de traitement d'une plaie
WO2007084792A2 (fr) 2006-01-23 2007-07-26 Kci Licensing, Inc. Système et procédé de traitement de plaie par débridement par ultrasons
EP1884223A1 (fr) * 2006-08-04 2008-02-06 IP Randwyck B.V. Unité de stimulation d'une plaie
EP2032112A2 (fr) * 2006-06-26 2009-03-11 Eilaz Babaev Dispositif et procédé de soin des blessures par ultrasons
EP2081629A2 (fr) * 2006-09-28 2009-07-29 Puricore Inc. Appareil et procédé pour traitement d'une blessure, d'une cavité chirurgicale ou d'un os
WO2010072349A1 (fr) * 2008-12-22 2010-07-01 Paul Hartmann Aktiengesellschaft Appareil de mesure pour des systèmes de traitement des plaies par pression négative
EP2395958A1 (fr) * 2009-02-12 2011-12-21 Perfuzia Medical, Inc. Dispositifs et procédés pour la manipulation de la circulation dans le système circulatoire d'un patient
US20130253453A1 (en) * 2008-11-19 2013-09-26 Kci Licensing, Inc. Dynamic, reduced-pressure treatment systems and methods
US8734325B2 (en) * 2006-06-07 2014-05-27 Trinity Wound Institute, Llc Oxygen therapy with ultrasound
US8834451B2 (en) 2002-10-28 2014-09-16 Smith & Nephew Plc In-situ wound cleansing apparatus
US8845619B2 (en) 2004-04-27 2014-09-30 Smith & Nephew Plc Wound treatment apparatus and method
CN104117101A (zh) * 2008-05-30 2014-10-29 凯希特许有限公司 在应用闭合力中使用的减压敷料组件
US9044569B2 (en) 2004-04-28 2015-06-02 Smith & Nephew Plc Wound dressing apparatus and method of use
US9050398B2 (en) 2010-12-22 2015-06-09 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
USD733321S1 (en) 2014-01-10 2015-06-30 Celleration, Inc. Ultrasonic treatment device
USD733319S1 (en) 2014-01-10 2015-06-30 Celleration, Inc. Ultrasonic treatment wand
CN104815358A (zh) * 2015-04-23 2015-08-05 广州新诚生物科技有限公司 可实现自循环的负压引流系统
US9198801B2 (en) 2004-04-05 2015-12-01 Bluesky Medical Group, Inc. Flexible reduced pressure treatment appliance
US9227000B2 (en) 2006-09-28 2016-01-05 Smith & Nephew, Inc. Portable wound therapy system
US9327065B2 (en) 2009-12-22 2016-05-03 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US9452244B2 (en) 2004-04-27 2016-09-27 Smith & Nephew Plc Wound cleansing apparatus with stress
AU2015227407B2 (en) * 2008-11-19 2017-05-25 3M Innovative Properties Company Dynamic, reduced-pressure treatment systems and methods
WO2017087687A1 (fr) * 2015-11-19 2017-05-26 Kci Licensing, Inc. Appareil et procédé de gestion de fluide
USD804014S1 (en) 2010-12-22 2017-11-28 Smith & Nephew, Inc. Suction adapter
US9956329B2 (en) 2008-03-07 2018-05-01 Smith & Nephew, Inc. Wound dressing port and associated wound dressing
US9956121B2 (en) 2007-11-21 2018-05-01 Smith & Nephew Plc Wound dressing
US10010658B2 (en) 2013-05-10 2018-07-03 Smith & Nephew Plc Fluidic connector for irrigation and aspiration of wounds
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US10071190B2 (en) 2008-02-27 2018-09-11 Smith & Nephew Plc Fluid collection
US10143784B2 (en) 2007-11-21 2018-12-04 T.J. Smith & Nephew Limited Suction device and dressing
US10207035B2 (en) 2004-05-21 2019-02-19 Smith & Nephew, Inc. Flexible reduced pressure treatment appliance
US10406036B2 (en) 2009-06-18 2019-09-10 Smith & Nephew, Inc. Apparatus for vacuum bridging and/or exudate collection
US10413644B2 (en) 2004-04-27 2019-09-17 Smith & Nephew Plc Wound treatment apparatus and method
USRE48117E1 (en) 2010-05-07 2020-07-28 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
WO2021044307A1 (fr) * 2019-09-04 2021-03-11 Kci Licensing, Inc. Mécanisme de vibration chargé à pression négative pour vibration de pansement intermittente
US20210402049A1 (en) * 2017-07-31 2021-12-30 Kci Usa, Inc. Bioresorbable dressing with structural support
US11298453B2 (en) 2003-10-28 2022-04-12 Smith & Nephew Plc Apparatus and method for wound cleansing with actives
US11364334B2 (en) 2018-08-21 2022-06-21 Kci Licensing, Inc. System and method for utilizing pressure decay to determine available fluid capacity in a negative pressure dressing
US11819386B2 (en) 2018-07-12 2023-11-21 T.J.Smith And Nephew, Limited Apparatuses and methods for negative pressure wound therapy
US11992601B2 (en) 2009-06-01 2024-05-28 Smith & Nephew, Inc. System for providing continual drainage in negative pressure wound therapy
US12016993B2 (en) 2020-01-15 2024-06-25 T.J.Smith And Nephew, Limited Fluidic connectors for negative pressure wound therapy

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001904A1 (fr) * 1982-11-17 1984-05-24 Gunnar Swanbeck Dispositif pour rincer et traitement des blessures et des parties de peau infectees
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
WO1999048621A2 (fr) 1998-03-26 1999-09-30 Exogen, Inc. Matrices d'elements transducteurs souples
WO1999056829A1 (fr) 1998-05-06 1999-11-11 Exogen, Inc. Bandages a ultrasons
WO2000050143A1 (fr) * 1999-02-26 2000-08-31 Nxstage, Inc. Systemes et procedes de dialyse peritoneale a ecoulement continu a regeneration de la solution de dialyse en ligne
US20030171675A1 (en) * 2000-08-03 2003-09-11 Lior Rosenberg System for enhanced chemical debridement
WO2004037334A1 (fr) * 2002-10-28 2004-05-06 Smith & Nephew Plc Appareil conçu pour aspirer, irriguer et nettoyer des plaies
WO2005051461A1 (fr) * 2003-10-28 2005-06-09 Smith & Nephew Plc Appareil de nettoyage de plaies in situ

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001904A1 (fr) * 1982-11-17 1984-05-24 Gunnar Swanbeck Dispositif pour rincer et traitement des blessures et des parties de peau infectees
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
WO1999048621A2 (fr) 1998-03-26 1999-09-30 Exogen, Inc. Matrices d'elements transducteurs souples
WO1999056829A1 (fr) 1998-05-06 1999-11-11 Exogen, Inc. Bandages a ultrasons
WO2000050143A1 (fr) * 1999-02-26 2000-08-31 Nxstage, Inc. Systemes et procedes de dialyse peritoneale a ecoulement continu a regeneration de la solution de dialyse en ligne
US20030171675A1 (en) * 2000-08-03 2003-09-11 Lior Rosenberg System for enhanced chemical debridement
WO2004037334A1 (fr) * 2002-10-28 2004-05-06 Smith & Nephew Plc Appareil conçu pour aspirer, irriguer et nettoyer des plaies
WO2005051461A1 (fr) * 2003-10-28 2005-06-09 Smith & Nephew Plc Appareil de nettoyage de plaies in situ

Cited By (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10278869B2 (en) 2002-10-28 2019-05-07 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US9844474B2 (en) 2002-10-28 2017-12-19 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US8834451B2 (en) 2002-10-28 2014-09-16 Smith & Nephew Plc In-situ wound cleansing apparatus
US10842678B2 (en) 2002-10-28 2020-11-24 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US9205001B2 (en) 2002-10-28 2015-12-08 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US9844473B2 (en) 2002-10-28 2017-12-19 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US9387126B2 (en) 2002-10-28 2016-07-12 Smith & Nephew Plc Apparatus for aspirating, irrigating and cleansing wounds
US11298453B2 (en) 2003-10-28 2022-04-12 Smith & Nephew Plc Apparatus and method for wound cleansing with actives
US11730874B2 (en) 2004-04-05 2023-08-22 Smith & Nephew, Inc. Reduced pressure treatment appliance
US10842919B2 (en) 2004-04-05 2020-11-24 Smith & Nephew, Inc. Reduced pressure treatment system
US10363346B2 (en) 2004-04-05 2019-07-30 Smith & Nephew, Inc. Flexible reduced pressure treatment appliance
US10350339B2 (en) 2004-04-05 2019-07-16 Smith & Nephew, Inc. Flexible reduced pressure treatment appliance
US10105471B2 (en) 2004-04-05 2018-10-23 Smith & Nephew, Inc. Reduced pressure treatment system
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US9198801B2 (en) 2004-04-05 2015-12-01 Bluesky Medical Group, Inc. Flexible reduced pressure treatment appliance
US10413644B2 (en) 2004-04-27 2019-09-17 Smith & Nephew Plc Wound treatment apparatus and method
US9526817B2 (en) 2004-04-27 2016-12-27 Smith & Nephew Plc Wound cleansing apparatus with stress
US11617823B2 (en) 2004-04-27 2023-04-04 Smith & Nephew Plc Wound cleansing apparatus with stress
US10342729B2 (en) 2004-04-27 2019-07-09 Smith & Nephew Plc Wound cleansing apparatus with stress
US8845619B2 (en) 2004-04-27 2014-09-30 Smith & Nephew Plc Wound treatment apparatus and method
US11013837B2 (en) 2004-04-27 2021-05-25 Smith & Nephew Plc Wound treatment apparatus and method
US9452244B2 (en) 2004-04-27 2016-09-27 Smith & Nephew Plc Wound cleansing apparatus with stress
US11426497B2 (en) 2004-04-27 2022-08-30 Smith & Nephew Plc Wound treatment apparatus and method
US10039868B2 (en) 2004-04-28 2018-08-07 Smith & Nephew Plc Dressing and apparatus for cleansing the wounds
US9545463B2 (en) 2004-04-28 2017-01-17 Smith & Nephew Plc Wound treatment apparatus and method
US9044569B2 (en) 2004-04-28 2015-06-02 Smith & Nephew Plc Wound dressing apparatus and method of use
US9950100B2 (en) 2004-04-28 2018-04-24 Smith & Nephew Plc Negative pressure wound therapy dressing system
US10758425B2 (en) 2004-04-28 2020-09-01 Smith & Nephew Plc Negative pressure wound therapy dressing system
US10758424B2 (en) 2004-04-28 2020-09-01 Smith & Nephew Plc Dressing and apparatus for cleansing the wounds
US10207035B2 (en) 2004-05-21 2019-02-19 Smith & Nephew, Inc. Flexible reduced pressure treatment appliance
EP3167916A1 (fr) * 2005-04-27 2017-05-17 Smith & Nephew PLC Appareil et methode de traitement d'une plaie
WO2006114648A3 (fr) * 2005-04-27 2007-04-19 Smith & Nephew Dispositif et procede pour le traitement de blessure
US10035006B2 (en) 2005-04-27 2018-07-31 Smith & Nephew Plc Wound treatment apparatus and method
WO2006114648A2 (fr) * 2005-04-27 2006-11-02 Smith & Nephew, Plc Dispositif et procede pour le traitement de blessure
WO2006114638A2 (fr) * 2005-04-27 2006-11-02 Smith & Nephew, Plc Appareil et methode de traitement d'une plaie
WO2006114638A3 (fr) * 2005-04-27 2007-03-08 Smith & Nephew Appareil et methode de traitement d'une plaie
US11147714B2 (en) 2005-04-27 2021-10-19 Smith & Nephew Plc Wound treatment apparatus and method
US9044579B2 (en) 2005-04-27 2015-06-02 Smith & Nephew Plc Wound treatment apparatus and method
EP1976477B2 (fr) † 2006-01-23 2023-03-01 KCI Licensing, Inc. Système de traitement de plaie par débridement par ultrasons
WO2007084792A2 (fr) 2006-01-23 2007-07-26 Kci Licensing, Inc. Système et procédé de traitement de plaie par débridement par ultrasons
EP1976477A4 (fr) * 2006-01-23 2016-03-09 Kci Licensing Inc Système et procédé de traitement de plaie par débridement par ultrasons
EP3287113A1 (fr) * 2006-01-23 2018-02-28 KCI Licensing, Inc. Système de traitement de plaie par débridement par ultrasons
EP3616669A1 (fr) * 2006-01-23 2020-03-04 KCI Licensing, Inc. Système de traitement d'une blessure par débridement ultrasonique
EP3287113B1 (fr) 2006-01-23 2019-10-30 KCI Licensing, Inc. Système de traitement de plaie par débridement par ultrasons
US8734325B2 (en) * 2006-06-07 2014-05-27 Trinity Wound Institute, Llc Oxygen therapy with ultrasound
EP2032112A4 (fr) * 2006-06-26 2010-04-07 Eilaz Babaev Dispositif et procédé de soin des blessures par ultrasons
EP2032112A2 (fr) * 2006-06-26 2009-03-11 Eilaz Babaev Dispositif et procédé de soin des blessures par ultrasons
WO2008016304A1 (fr) * 2006-08-04 2008-02-07 Ip Randwyck B.V. Unité de stimulation de plaie
EP1884223A1 (fr) * 2006-08-04 2008-02-06 IP Randwyck B.V. Unité de stimulation d'une plaie
US12115302B2 (en) 2006-09-28 2024-10-15 Smith & Nephew, Inc. Portable wound therapy system
EP2081629A4 (fr) * 2006-09-28 2014-06-25 Puricore Inc Appareil et procédé pour traitement d'une blessure, d'une cavité chirurgicale ou d'un os
US11141325B2 (en) 2006-09-28 2021-10-12 Smith & Nephew, Inc. Portable wound therapy system
US9642955B2 (en) 2006-09-28 2017-05-09 Smith & Nephew, Inc. Portable wound therapy system
EP2081629A2 (fr) * 2006-09-28 2009-07-29 Puricore Inc. Appareil et procédé pour traitement d'une blessure, d'une cavité chirurgicale ou d'un os
US9227000B2 (en) 2006-09-28 2016-01-05 Smith & Nephew, Inc. Portable wound therapy system
US10130526B2 (en) 2006-09-28 2018-11-20 Smith & Nephew, Inc. Portable wound therapy system
US11179276B2 (en) 2007-11-21 2021-11-23 Smith & Nephew Plc Wound dressing
US11364151B2 (en) 2007-11-21 2022-06-21 Smith & Nephew Plc Wound dressing
US11766512B2 (en) 2007-11-21 2023-09-26 T.J.Smith And Nephew, Limited Suction device and dressing
US11129751B2 (en) 2007-11-21 2021-09-28 Smith & Nephew Plc Wound dressing
US10143784B2 (en) 2007-11-21 2018-12-04 T.J. Smith & Nephew Limited Suction device and dressing
US10744041B2 (en) 2007-11-21 2020-08-18 Smith & Nephew Plc Wound dressing
US10231875B2 (en) 2007-11-21 2019-03-19 Smith & Nephew Plc Wound dressing
US10555839B2 (en) 2007-11-21 2020-02-11 Smith & Nephew Plc Wound dressing
US9956121B2 (en) 2007-11-21 2018-05-01 Smith & Nephew Plc Wound dressing
US10016309B2 (en) 2007-11-21 2018-07-10 Smith & Nephew Plc Wound dressing
US11351064B2 (en) 2007-11-21 2022-06-07 Smith & Nephew Plc Wound dressing
US11344663B2 (en) 2007-11-21 2022-05-31 T.J.Smith And Nephew, Limited Suction device and dressing
US10071190B2 (en) 2008-02-27 2018-09-11 Smith & Nephew Plc Fluid collection
US11141520B2 (en) 2008-02-27 2021-10-12 Smith & Nephew Plc Fluid collection
US9956329B2 (en) 2008-03-07 2018-05-01 Smith & Nephew, Inc. Wound dressing port and associated wound dressing
CN104117101A (zh) * 2008-05-30 2014-10-29 凯希特许有限公司 在应用闭合力中使用的减压敷料组件
US9186442B2 (en) * 2008-11-19 2015-11-17 Kci Licensing, Inc. Dynamic, reduced-pressure treatment systems and methods
US20130253453A1 (en) * 2008-11-19 2013-09-26 Kci Licensing, Inc. Dynamic, reduced-pressure treatment systems and methods
AU2015227407B2 (en) * 2008-11-19 2017-05-25 3M Innovative Properties Company Dynamic, reduced-pressure treatment systems and methods
WO2010072349A1 (fr) * 2008-12-22 2010-07-01 Paul Hartmann Aktiengesellschaft Appareil de mesure pour des systèmes de traitement des plaies par pression négative
CN102256639A (zh) * 2008-12-22 2011-11-23 保罗·哈特曼股份公司 用于处理创伤的负压治疗系统的测量设备
US8635921B2 (en) 2008-12-22 2014-01-28 Paul Hartmann Aktiengesellschaft Measurement apparatus for vacuum therapy systems for wound treatment
EP2395958A4 (fr) * 2009-02-12 2013-12-18 Perfuzia Medical Inc Dispositifs et procédés pour la manipulation de la circulation dans le système circulatoire d'un patient
EP2395958A1 (fr) * 2009-02-12 2011-12-21 Perfuzia Medical, Inc. Dispositifs et procédés pour la manipulation de la circulation dans le système circulatoire d'un patient
US11992601B2 (en) 2009-06-01 2024-05-28 Smith & Nephew, Inc. System for providing continual drainage in negative pressure wound therapy
US10406036B2 (en) 2009-06-18 2019-09-10 Smith & Nephew, Inc. Apparatus for vacuum bridging and/or exudate collection
US9999547B2 (en) 2009-12-22 2018-06-19 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US9974695B2 (en) 2009-12-22 2018-05-22 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US9327065B2 (en) 2009-12-22 2016-05-03 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US9642750B2 (en) 2009-12-22 2017-05-09 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US10406037B2 (en) 2009-12-22 2019-09-10 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US12082996B2 (en) 2009-12-22 2024-09-10 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US11058588B2 (en) 2009-12-22 2021-07-13 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
USRE48117E1 (en) 2010-05-07 2020-07-28 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US11247034B2 (en) 2010-12-22 2022-02-15 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US9956389B2 (en) 2010-12-22 2018-05-01 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
USD804014S1 (en) 2010-12-22 2017-11-28 Smith & Nephew, Inc. Suction adapter
US9050398B2 (en) 2010-12-22 2015-06-09 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
US10010658B2 (en) 2013-05-10 2018-07-03 Smith & Nephew Plc Fluidic connector for irrigation and aspiration of wounds
US11439741B2 (en) 2013-05-10 2022-09-13 Smith & Nephew Plc Fluidic connector for irrigation and aspiration of wounds
USD733321S1 (en) 2014-01-10 2015-06-30 Celleration, Inc. Ultrasonic treatment device
USD733319S1 (en) 2014-01-10 2015-06-30 Celleration, Inc. Ultrasonic treatment wand
CN104815358A (zh) * 2015-04-23 2015-08-05 广州新诚生物科技有限公司 可实现自循环的负压引流系统
US11253640B2 (en) 2015-11-19 2022-02-22 Kci Licensing, Inc. Fluid management apparatus and method
WO2017087687A1 (fr) * 2015-11-19 2017-05-26 Kci Licensing, Inc. Appareil et procédé de gestion de fluide
US11717592B2 (en) * 2017-07-31 2023-08-08 Kci Licensing, Inc. Bioresorbable dressing with structural support
US20210402049A1 (en) * 2017-07-31 2021-12-30 Kci Usa, Inc. Bioresorbable dressing with structural support
US11819386B2 (en) 2018-07-12 2023-11-21 T.J.Smith And Nephew, Limited Apparatuses and methods for negative pressure wound therapy
US11364334B2 (en) 2018-08-21 2022-06-21 Kci Licensing, Inc. System and method for utilizing pressure decay to determine available fluid capacity in a negative pressure dressing
WO2021044307A1 (fr) * 2019-09-04 2021-03-11 Kci Licensing, Inc. Mécanisme de vibration chargé à pression négative pour vibration de pansement intermittente
US12016993B2 (en) 2020-01-15 2024-06-25 T.J.Smith And Nephew, Limited Fluidic connectors for negative pressure wound therapy

Also Published As

Publication number Publication date
GB0409292D0 (en) 2004-06-02

Similar Documents

Publication Publication Date Title
US11617823B2 (en) Wound cleansing apparatus with stress
CA2564985C (fr) Dispositif de nettoyage des plaies par application d'une contrainte
WO2005105175A1 (fr) Appareil de nettoyage de blessures a ultrasons
CA2543356C (fr) Dispositifs de nettoyage des plaies au moyen de substances actives
US9289542B2 (en) Wound cleansing apparatus
CA2543936C (fr) Dispositif de nettoyage des plaies avec echafaudage
CA2606245C (fr) Appareil et methode de traitement d'une plaie
WO2005105176A1 (fr) Appareil de nettoyage de blessures a contrainte d'ecoulement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase